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Drug misuse wastes lives, destroys 
families and damages communities.  
It costs taxpayers millions to deal with  
the health problems caused by drugs and 
to tackle the crimes such as burglary,  
car theft, mugging and robbery which are 
committed by some users to fund their 
habit. The drug trade is linked to serious 
organised crime, including prostitution 
and the trafficking of people and firearms. 
Drugs remain a serious and complex 
problem that we – along with all modern 
societies – must face. 
We now know that we can succeed in 
tackling drugs because the last ten years 
have seen progress and some notable 
successes. The percentage of people – 
including young people – who use illegal 
drugs has fallen since 1998. Because we 
have invested in drug treatment, we are 
getting people into treatment faster, with 
people waiting on average less than two-
and-a-half weeks for treatment, rather 
than nine weeks in 2001. Overall, we have 
more than doubled the numbers of people 
accessing drug treatment. We have targeted 
those who commit crime to feed their 
addiction by using compulsory drug testing 
on arrest and assessment by a drugs worker. 
This is backed up by tough sanctions for 
those who do not comply, including, in 
some cases, custodial sentences. This has 
contributed to a fall in recorded acquisitive 
crime of around 20 per cent. And because 
the police and their partners are making 
full use of new powers introduced by the 
Government, communities are seeing action 
Home Secretary’s foreword
and tangible results – over 1,000 crack 
houses have been closed since 2003, and 
we are seizing more of the assets of drug 
dealers. 
But we also know there is more to be done. 
Overall drug use is down, but the use of 
cocaine and heroin has remained stable in 
recent years. And although cannabis use is 
down overall, we know that stronger types 
of cannabis are available. The number of 
cannabis factories being detected has also 
risen dramatically in the past two years. 
While we have been successful at fast-
tracking people into treatment, we need 
to focus more upon treatment outcomes, 
with a greater proportion free from their 
dependence and being re-integrated into 
society, coming off benefits and getting back 
to work. We have also sometimes focused 
too much on the individual drug user and 
not enough on their family and the wider 
community. 
Our ambition is clear. We want a society 
free of the problems caused by drugs. Our 
aim is that fewer and fewer people start 
using drugs; that those who do use drugs 
not only enter treatment, but complete 
it and re-establish their lives; and that 
communities are free of drug-related crime, 
anti-social behaviour and the fear these 
cause. We know that this is long-term work 
and will mean dealing not just with drug 
problems, but with the problems in societies, 
communities and families that can make 
people susceptible to drug use, and can 
act as barriers to recovery. All societies face 
these problems, and there are no instant 
solutions. 
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Our new strategy will build on the success 
of the past ten years, but also learn lessons. 
The difference that the new strategy brings is 
that we will: 
focus more on •	 families, addressing 
the needs of parents and children as 
individuals, as well as working with whole 
families to prevent drug use, reduce risk, 
and get people into treatment;
give a stronger role to •	 communities, 
protecting them from the damage that 
drugs cause through strong enforcement 
action, using all available powers, 
sanctions and levers, giving them a voice 
and listening to their concerns;
target money and effort•	  where we will 
make the most difference by making 
sure people are successfully completing 
treatment and re-establishing their lives, 
and by focusing on the drug users 
causing the most harm to communities;
work together•	  on shared problems 
across institutional boundaries – for 
example, ensuring that children’s social 
services know about drug-using parents 
where children are at risk as a result of 
their drug use, or local communities can 
work with police and other agencies 
to disrupt and dismantle open street 
markets and close down cannabis 
factories and crack houses; and
be clear that drug users •	 have a 
responsibility to engage in treatment in 
return for the help and support available.
On enforcement, we will: 
prosecute drug dealers and those •	
committing crime to feed their addiction, 
drug-test on arrest, getting drug-misusing 
offenders into effective treatment and 
improving prison treatment programmes, 
while increasing the use of community 
sentences with a Drug Rehabilitation 
Requirement (DRR);
use Neighbourhood Policing to gather •	
community intelligence leading to more 
drug dealers’ assets being seized as well 
as more dealers going to prison – with 
more powers to seize assets more easily, 
making it clear that money cannot be 
earned from drugs with impunity;
work with international partners to •	
intercept drugs before they reach the UK’s 
borders and disrupt and dismantle serious 
and organised crime through the Serious 
Organised Crime Agency (SOCA), police 
forces and HM Revenue and Customs 
(HMRC); and
back parents and communities who want •	
to take action, supporting the use of 
local campaigns such as ‘Rat on a Rat’, 
allowing communities to report dealers 
anonymously in their local area.
On treatment, we will:
clearly prioritise those who are causing •	
the most harm to communities and 
families – getting offenders, and parents 
whose drug use may put their children at 
risk, into effective treatment quickly;
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pilot the use of individual budgets to help •	
those successfully completing treatment 
to access housing, employment, 
education and training, to support them 
in re-establishing their lives, free from 
dependency;
use all emerging and all available evidence •	
to make sure we are supporting the 
treatment that is most effective, targeted 
on the right users – with abstinence-based 
treatment for some, drug-replacement 
over time for others, and innovative 
treatments including injectable heroin and 
methadone where they have been proved 
to work and reduce crime;
involve families and carers in the planning •	
and process of treatment, for young 
people and for adults; and 
ensure that the benefits system supports •	
our new focus on re-integration and 
personalisation. In order to ensure that 
it provides the right level of support and 
creates incentives for people with drug 
problems to move towards treatment, 
training and employment, we will at a 
minimum:
require drug misusers on out-of-work  –
benefits to attend a discussion with 
an appropriate specialist treatment 
provider or partner organisation as 
part of the Jobseeker Direction or 
Work Focused Interview requirements; 
and 
encourage closer links between  –
relevant agencies so that drug 
misusers who are claiming benefits 
can be referred to specialist services.
These changes are a first step in helping 
clients to overcome barriers to work and 
ensuring Jobcentre Plus engages more 
closely with local drug partnerships and 
treatment providers in all areas where this 
is not already happening. However, we do 
not think it is right for the taxpayer to help 
sustain drug habits when individuals could 
be getting treatment to overcome barriers 
to employment. So, we will explore the 
case for introducing a new regime which 
provides more tailored and personalised 
support than that which is currently 
provided by the existing Incapacity Benefit 
or Jobseeker Allowance regimes. In return 
for benefit payments, claimants will have a 
responsibility to move successfully through 
treatment and into employment. Further 
proposals will be announced regarding 
these measures. 
On prevention, we will: 
expand our approach so that it •	
increasingly focuses on young children 
and families before problems have arisen;
take a wider preventative view that is •	
not focused just on illegal drugs, but on 
all substances and the risk factors that 
we know can lead to drug use, alcohol 
misuse and volatile substance abuse 
(gases, glues and solvents) as well as 
other problems later in life;
look at the whole family, ensuring prompt •	
access to treatment for drug-misusing 
parents with treatment needs and 
particularly those whose children are at 
risk, with assessments taking account 
of family needs, and providing intensive 
parenting support alongside drug 
treatment; and
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ensure drug-misusing parents, and other •	
at-risk parents, including offenders and 
their partners, are a target group for new 
parenting experts and in plans to develop 
Family Intervention Projects – which are 
already working intensively with around 
1,500 families engaged in anti-social 
behaviour – and Family Pathfinders for 
wider types of families at risk.
On communications, we will: 
send a clear signal about the damaging •	
consequences of all harmful substances, 
working with parents and children to 
give information and advice and with 
communities to build reassurance 
and show that action is being taken. 
The successful FRANK campaign 
will continue to provide honest and 
confidential information to children and 
young people; and
give parents and extended families better •	
and more accessible advice about how 
to talk to children about drugs, and about 
what to do if they suspect their child may 
have a problem.
Through our new drug strategy, and the 
action that will flow from it, we will continue 
to send a clear message that drug use is 
unacceptable; that we are on the side of 
communities; that we demand respect for 
the law and will not tolerate illegal or anti-
social behaviour; but that we will provide 
help for those who are trying to turn their 
lives around, to get off drugs and into work, 
to ensure drug problems are not handed on 
to the next generation; and that we expect 
drug users themselves to take responsibility, 
and will help them to do so. 
Jacqui Smith 
Home Secretary
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Executive summary
Illegal drugs bring with them a range of 
problems and they are a major issue of 
public concern. The harms they cause 
are significant, wide-ranging and costly, 
with the use of Class A drugs generating 
an estimated £15 billion in economic 
and social costs. While all drugs have 
damaging impacts, the most harmful 
drugs, including heroin and crack cocaine, 
bring untold misery to individuals, their 
families and communities. Problem drug 
use is an issue which has an impact on 
society as a whole, but disproportionately 
affects the most deprived communities, 
disadvantaged families and vulnerable 
individuals. 
The Government’s 1998 drug strategy, 
with its 2002 update, set a framework to 
address the harms caused by the supply 
of and demand for drugs. This has allowed 
the Government and its partners to achieve 
many of the strategy’s aims and there is 
much for us to build upon. We have seen 
reductions in drug-related harm and drug-
related crime and increased treatment 
provision, with increasing numbers of 
offenders referred into treatment from the 
criminal justice system. 
Illegal drugs are part of a global industry 
that relies on the exploitation of the poorest 
people in producer and transit countries 
and traps many others in a cycle of crime 
and deprivation in target countries such 
as our own. The most damaging effects 
for communities are those caused by drug 
dealing, drug-related crime and anti-social 
behaviour, which can undermine stable 
families and cohesive communities. 
Drug misuse can prevent parents from 
providing their children with the care and 
support they need and greatly increases 
the likelihood that their children will grow 
up to develop drug problems themselves. 
It creates chronic health problems that 
destroy lives and it prevents young people 
from succeeding in education, being healthy 
and fulfilling their potential. 
Our challenge
We know from the latest available 
evidence that: 
there are an estimated 332,000 •	
problem drug users in England;
Class A drug use generates an •	
estimated £15.4 billion in crime 
and health costs each year, of which 
99 per cent is accounted for by 
problem drug users;
between a third and a half of •	
acquisitive crime is estimated to be 
drug related;
around a quarter (24 per cent) of •	
young people aged 16–24 have used 
an illegal drug in the last year;
10 per cent of people aged 16–59 •	
have used an illegal drug in the 
last year;
17 per cent of school children aged •	
11–15 have used an illegal drug in the 
last year; and
the UK illicit drug market is estimated •	
to be worth between £4 billion and 
£6.6 billion.
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Public Service Agreements – meeting our targets
Significant progress has been made against our Public Service Agreement (PSA) targets. Drug-related 
harm is measured by the Drug Harm Index, which shows a reduction of 28.4 per cent between 2002, 
the reference year for the PSA, and 2005, the latest available measurement. Drug-related crime has fallen 
significantly since the introduction of the Drug Interventions Programme (DIP) in 2003 (see below) and we 
are on track to meet our target to direct 1,000 drug-misusing offenders into treatment each week. 
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Crack houses are closed more rapidly using 
new enforcement powers and drug dealers 
have had their assets seized and reinvested 
in the communities they have damaged. We 
have focused on identifying and intervening 
with the young people who are most at risk 
of developing substance misuse problems, 
to prevent such problems occurring.
While we have made a great deal of 
progress, more remains to be done. Despite 
drug use being at its lowest level since 
1998, it remains high, with 10 per cent of 
people using an illegal drug in the past year 
(see graph) and more than a quarter of 
people thinking that drug use or dealing is 
a very or fairly big problem in their area.1
Although drug-related crime continues to 
fall, that reduction has recently slowed. 
We must therefore continue to prioritise 
efforts to identify problematic drug users 
and get them into treatment, driving down 
drug misuse, drug-related crime and the 
associated costs. 
The impact of substance misuse on 
children and families can be significant 
and long-lasting, but has previously been 
underestimated. Parental drug use can 
cause children a wide range of health and 
developmental problems. It also limits 
the capacity for effective parenting, and 
many of the impacts of parental drug use, 
such as emotional insecurity, irregular 
school attendance and lack of suitable role 
models, can be drivers for other problems, 
including involvement in youth crime or low 
educational attainment. We must prioritise 
efforts to identify children and families at 
risk from substance misuse and provide 
appropriate interventions to address the 
challenges they face.
Drugs: our community, your say
To inform the development of the drug strategy, and 
to ensure that it is responsive to the issues that are of 
concern to communities, the Government launched a 
public consultation in July 2007. More than a thousand 
written responses were received and interviews were 
conducted with stakeholders, communities and service 
user representatives. A summary of responses received is 
available on the Home Office drugs website. 
Priorities identified during the consultation process, to 
which this strategy responds, include:
visible and effective action against dealers, responding •	
to community concerns and providing timely feedback 
on action taken;
action to support the children of drug misusers and to •	
intervene with families at risk of suffering harms;
targeted interventions for vulnerable young people;•	
local information and prevention campaigns;•	
more personalised treatment services, with better •	
support to help people to complete treatment and to 
re-establish their lives; 
improved guidance on commissioning and flexibility in •	
the use of resources;
a commitment to improve the evidence supporting the •	
strategy; and
a clear commitment to meet the needs of all our •	
diverse communities. 
1 British Crime Survey 2006/07.
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Our vision is to produce a long-term 
and sustainable reduction in the harms 
associated with drugs; helping to promote 
drug-free futures and drug-free streets 
for children, families and communities. 
We will combine tough enforcement 
action against those whose dealing and 
offending threatens communities with strong 
prevention and early intervention to address 
problems before they develop, intervening 
swiftly when they do. We will maximise the 
impact of the significant resources spent on 
treatment by better targeting and tailoring 
interventions and supporting users to move 
on from treatment and re-integrate into 
communities.
In order to achieve this vision, we will 
strengthen those areas where we have been 
effective, but also test and implement new 
interventions where changes need to be 
made. In practice, this means:
Protecting communities through •	
robust enforcement to tackle drug 
supply, drug-related crime and anti-
social behaviour. Developing ways to 
regularly engage and respond to the 
needs of communities and to increase 
the seizure of criminal assets, delivering 
visible benefits to communities and 
strengthening the capacity of agencies to 
tackle crime in their areas and the supply 
of drugs into and within the UK. We will 
reduce drug-related offending through 
more effective targeting and offender 
management, continuing to identify and 
grip drug-misusing offenders, so that 
we drive down anti-social behaviour and 
crimes such as burglary and robbery, 
which have such a corrosive effect on the 
confidence of communities.
Preventing harm to children, young •	
people and families affected by drug 
misuse. Targeting interventions on those 
young people and families most at risk 
of suffering harms caused by substance 
misuse. We will intervene earlier with 
young people to prevent immediate 
harms and to avert future problematic 
drug use and we will provide prompt 
and tailored support to families with 
substance-misusing parents. Providing 
a family focus will ensure that the needs 
of the children and families of drug users 
are given a greater priority than they have 
previously received.
Delivering new approaches to drug •	
treatment and social re-integration. 
We will further reform the way treatment 
is provided, offering services such as 
training and support in getting work, 
alongside drug treatment. We will also 
use the benefits system to support this 
new focus on re-integration, providing 
the right level of support for people 
with drug problems to move towards 
treatment, training and employment. This 
will allow us to respond more directly to 
individual needs, helping drug misusers 
to overcome dependence and re-
establish their lives. The previous strategy 
successfully delivered an expanded 
and accessible treatment system. This 
strategy builds on this to focus more on 
the longer-term outcomes of treatment, 
including its impact on crime, health and 
harms caused to families.
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Public information campaigns, •	
communications and community 
engagement. Developing 
communication and education 
campaigns, involving young people, 
communities, families and parents to 
make clear the harms that all drugs can 
cause, supporting informed decisions 
and determining locally appropriate 
responses to drug misuse.
We will concentrate our efforts on supporting 
communities and families. We firmly believe 
that when communities work together, they 
are more able to prevent and resist the harms 
caused by drugs. Local areas will have 
greater autonomy and flexibility to respond to 
the local needs and to the priorities of local 
communities, and this flexibility will underpin 
our new approach.
While our focus will remain on the drugs that 
cause the greatest harms to communities, 
families and individuals, local areas will have 
more flexibility to determine their response 
to the drugs which are causing the greatest 
harm to their communities. For young 
people, all substances should be addressed, 
including alcohol and volatile substances 
such as gases, glues and solvents. The 
Pooled Treatment Budget will continue to be 
available to support treatment for all forms 
of substance misuse among young people 
below the age of 18. Although the Pooled 
Treatment Budget for adults will remain 
beyond use for the provision of primary 
alcohol misuse treatment, it may be right in 
some communities for plans to tackle drug 
use to be developed alongside action to 
tackle harmful drinking.
PSA 25 Reduce the harm 
caused by alcohol 
and drugs
The number of drug users 
recorded as being in effective 
treatment
The rate of drug-related offending
The percentage of the public who 
perceive drug use or dealing to 
be a problem in their area
PSA 14 Increase the 
number of children 
and young people 
on the path to 
success
The proportion of young people 
frequently using illicit drugs, 
alcohol or volatile substances
This strategy underpins action to reach 
our new PSA targets for 2008–11, which, 
for drugs, are measured by the following 
indicators:
These targets reflect our new focus on 
protecting communities and on preventing 
harm to young people, while stepping up 
action against drug dealers and offenders 
and increasing our efforts to achieve 
better treatment outcomes. The new 
Local Performance Framework, which 
has a single set of 198 national indicators, 
includes a number of indicators that are also 
common to the Assessments of Policing 
and Community Safety (APACS) framework. 
This framework moves us towards localised 
service delivery, which will result in more 
effective local engagement and identification 
of priorities. This will allow local areas to 
make the most efficient use of resources to 
meet local needs. Within this new delivery 
regime, any action taken at a local level to 
prioritise and tackle issues related to drug 
misuse, such as crime, anti-social behaviour 
and social exclusion, will also have an 
impact on drug and substance misuse. 
 Drugs: protecting families and communities  13
The national and local voluntary sector 
makes a significant and valuable contribution 
to the delivery of the drug strategy. 
Organisations in this sector are able to work 
flexibly across all themes of the strategy and 
can respond quickly to changing demands 
and environments. They can work effectively 
in partnership with other agencies and 
organisations, including those from the 
statutory and private sectors, to contribute 
to delivery of the objectives of the strategy, 
to build service and workforce capacity and 
to support the process of mainstreaming 
substance misuse.
Across the entire strategy – including 
how it is delivered at a local level – we will 
enhance our knowledge of what works 
and what delivers the most effective and 
efficient services by conducting a cross-
government programme of research and 
pilot programmes. More information on the 
evidence which supports the strategy and 
our priorities for developing a programme of 
research are set out in an appendix to this 
strategy.
This strategy provides an overarching 
framework of objectives and aspirations. 
Within this framework is a series of 
three-year Action Plans, which will run 
concurrently with the Government’s 
Comprehensive Spending Review cycles 
and new PSA targets. This will ensure 
resources and priorities are aligned. The 
strategy will be implemented in the context 
of the comprehensive national legislation on 
drugs and the obligations of international 
drugs Conventions. 
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Meeting our targets
This section of the strategy drives delivery against the 
2008–11 PSA targets relating to:
the rate of drug-related offending (PSA 25); and•	
the percentage of the public who perceive drug use •	
or dealing to be a problem in their area (PSA 25).
National indicators relating to this section include:
NI16 – serious acquisitive crime rate;•	
NI17 – perceptions of anti-social behaviour;•	
NI18 – adult re-offending rates for those under •	
probation supervision;
NI21 – dealing with local concerns about anti-social •	
behaviour and crime by the local council and police; 
NI30 – re-offending rate of prolific and priority •	
offenders; and
NI38 – drug-related (Class A) offending rate.•	
Responding to the challenge 
Protecting communities through robust enforcement 
to tackle drug supply, drug-related crime and  
anti-social behaviour
Drug-related offending, violence and anti-social 
behaviour have the greatest visible impact on 
communities. Interventions to address these 
harms need to span supply and demand 
reduction, with action to tackle the supply 
of drugs from overseas combined with local 
enforcement activity and interventions to 
address drug-related offending. 
The previous drug strategy delivered some 
notable successes in addressing drug 
supply and drug-related offending and 
identifying effective approaches:
Reducing drug-related offending  
and re-offending
The Drug Interventions Programme (DIP) •	
has made drug-misusing offenders face 
tough choices about their drug use and 
need for treatment, and research shows 
that offending levels can fall substantially 
following contact with the programme. 
Key strategy actions
Use multi-agency and intelligence-based approaches to identify the drug-misusing offenders at •	
greatest risk of causing the most harm and improve our responses to divert them out of crime.
Embed action to tackle drugs within the Neighbourhood Policing approach, responding to •	
community concerns about drugs, acting on intelligence provided by the community and giving 
feedback on how such intelligence was used.
Support communities who wish to take action against drug dealing by promoting local •	
campaigns such as ‘Rat on a Rat’. 
Create more international partnerships to intercept drugs being trafficked to the UK and to •	
implement border controls in countries of departure.
Extend asset seizure powers, including entering asset-sharing agreements with other countries •	
to allow the seizure of criminal assets sequestered overseas, and introducing powers to seize 
high-value goods at arrest.
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The introduction and improving •	
performance of both the Drug 
Treatment and Testing Order (DTTO) 
and the Community Order with a Drug 
Rehabilitation Requirement (DRR) has 
seen rising completion rates. This is 
encouraging, as we know from research 
that offenders who have completed DTTOs 
have significantly lower reconviction rates 
than those who have not. 
Increased funding for prison drug •	
treatment has enabled a further roll-
out of the clinical elements of the 
Integrated Drug Treatment System 
(IDTS), supported by a flexible framework 
of supply reduction measures, and an 
extensive programme of mandatory and 
voluntary drug testing.
A growing body of evidence shows that 
retaining offenders in treatment through the 
criminal justice system can reduce drug-
related offending. For example, the DRR, 
which is part of a community sentence, or the 
range of DIP interventions, can be effective in 
reducing re-offending by engaging offenders 
in treatment and addressing the underlying 
causes of their offending. The Strategic 
Plan to Reduce Re-Offending emphasises 
the role of effective offender management 
as the primary means to co-ordinate drug-
related interventions both in custody and 
the community. 
Local enforcement
Existing legislation gives powers to 
the police and other law enforcement 
agencies to:
apply tougher sanctions against those •	
dealing drugs on or in the vicinity of 
school premises, protecting young 
people from dealers;
rapidly close crack houses and other •	
drug dens, restoring community safety 
and confidence; and
seize the assets of convicted criminals •	
and reinvest them in crime reduction 
programmes.
Number entering treatment (DIP) April 2003 to November 2007
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We know that the Neighbourhood 
Policing approach, whereby the police 
seek to build closer relationships with the 
communities they serve, is effective. We 
will embed action to tackle drugs within this 
approach and promote the development of 
communications which will strengthen this 
relationship, showing communities where 
action is being taken to respond to local 
priorities, and building confidence.
Supply reduction
There is some evidence that enforcement 
activity can affect drug prices. Debriefing of 
drug traffickers shows they are in no doubt 
that enforcement effort has an impact on 
price; there is evidence of the UK wholesale 
price being greater than that in continental 
markets, and there is evidence from other 
countries of enforcement-driven price 
effects. As part of the wider drug strategy 
the Government believes that taking action 
to increase the price of drugs is worthwhile. 
We would expect higher prices to deter 
new users, encourage those reaching the 
end of their drug-using career to stop and 
reduce to some degree the consumption of 
current users. 
Our future approach
Building on our successes and our 
knowledge of what works, the Government 
will work with local and regional partners 
to ensure that a co-ordinated approach is 
taken to addressing drug-related offending 
and anti-social behaviour, to identifying and 
intervening with drug-misusing offenders, 
both in the community and in custody, to 
tackling the supply of drugs and to taking 
stronger measures against dealers. The 
approach will consist of the following four 
key elements:
Proactively targeting and managing 
drug-misusing offenders
To ensure that those who cause the most 
harm are identified, properly managed and 
receive appropriate and timely interventions, 
the Home Office, Ministry of Justice, 
prosecutors, police and partners will:
continue to present drug-misusing •	
offenders with tough choices to 
change their behaviour or face the 
consequences;
ensure that DIP-based powers, such as •	
drug testing, required assessment and 
restriction on bail, are effectively applied 
at a local level; and 
keep those powers under review, for •	
example by considering the range of 
substances for which an offender is 
tested, where emerging new drugs 
pose a threat to continued reductions 
in offending.
We will increase the number and range 
of offenders brought within these 
arrangements by: 
promoting an integrated approach to •	
managing offenders, sharing information 
and risk assessments across different 
agencies to better identify priority 
offenders and the interventions needed  
to address their offending;
supporting new areas and partnerships •	
to expand the range of DIP interventions 
available locally, including, for example, 
through self-funding of drug testing 
regimes; 
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increasing the number of offenders •	
whose drug-related offending is 
addressed through the use of DIP 
conditional cautions; and
managing offenders better at crucial •	
times, such as on discharge into the 
community from prison, when the risks 
of relapse and re-offending are high 
by improving the continuity of case 
management of drug-misusing offenders 
and reviewing and strengthening links 
between prisons, local Criminal Justice 
Integrated Teams and probation services.
Maximising the effectiveness of 
prison and community sentences
The Ministry of Justice will lead on 
maximising the impact of prison and 
community sentences to reduce drug 
misuse and its related harms. In conjunction 
with the Department of Health and other 
partners, this will be achieved by:
maximising the use of community •	
sentences with DRRs;
ensuring that all prisoners have access •	
to a minimum standard of clinical drug 
treatment;
exploring the scope for streamlining •	
funding and commissioning arrangements 
for the National Offender Management 
Service, Primary Care Trusts and 
Joint Commissioning Groups through 
commissioning and delivery pilots; 
extending the use of successful •	
interventions throughout the criminal 
justice system, including further rolling 
out of the IDTS;
piloting the introduction of the National •	
Drug Treatment Monitoring System into 
prisons and ensuring that community-
based treatment services are notified 
when a drug user is released from prison, 
to provide a better link between prison 
and community-based services;
raising the quality of interventions in the •	
prison estate and developing the skills of 
the workforce in prisons and probation 
services, so that they can deliver quality 
drugs services;
examining the potential of offering •	
sentencers additional community-based 
options for substance misusers within 
the intensive alternative to custody 
programme;
extending the successful Dedicated •	
Drug Court pilots, in which courts look 
to address drug misuse as a cause of 
offending, to up to four further areas, 
subject to evaluation of the Leeds and 
West London pilots; and
improving measures to control the supply •	
of drugs into prisons, including looking 
at conducting more rigorous searches, 
employing more sniffer dogs, and, 
where possible, extending the use of 
drug-free wings.
Engaging and empowering 
communities with stronger, locally-
responsive law enforcement
The Neighbourhood Policing approach 
means the police and other enforcement 
agencies will listen and respond to 
community concerns about drugs, act on 
intelligence supplied, provide information 
on the results of action taken and seek 
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feedback on it. All relevant agencies will 
ensure that action to prevent and tackle 
drugs sits at the heart of this policing 
strategy and that all available powers, levers 
and sanctions will be used to:
maximise the use of intelligence gathered •	
from the community;
disrupt and dismantle drug markets; •	
seize the cash and assets of drug •	
dealers; and
make greater use of post-conviction •	
Anti-Social Behaviour Orders (ASBOs), to 
prevent those convicted of drug dealing 
from re-establishing their business.
We will seize more of the cash and assets 
generated by drug dealing and bring greater 
pressure to bear on dealers by implementing 
and building on measures set out in the Asset 
Recovery Action Plan and by strengthening 
the powers contained in the Proceeds 
of Crime Act 2002. Measures which will 
be introduced to enable law enforcement 
agencies – working closely with the Crown 
Prosecution Service and the Revenue and 
Customs Prosecutions Office – to remove 
the financial benefits enjoyed by drug dealers 
will include:
powers to physically seize high-value •	
goods at the time of arrest, when it is 
anticipated that a confiscation process 
will be initiated, to prevent assets being 
removed;
widening the categories of assets liable •	
to civil recovery and extending the time 
limits for their recovery to take place; and
creating a new principle of sentencing •	
that all criminal gains should be removed.
Post-conviction ASBOs set out conditions 
which an individual must adhere to. For 
those convicted of drug offences, these 
conditions may include refraining from 
specific activity linked to their conviction or 
from entering specific areas. We will make 
greater use of these orders, to make it 
difficult for those convicted of drug dealing 
to re-establish their business.
More robust local law enforcement will 
result in:
Drug dealers identified and markets •	
disrupted by maximising community 
intelligence. Local communities can 
provide good quality intelligence and local 
media initiatives, such as the ‘Rat on a 
Rat’ campaign, have been successful. 
Open drug markets disrupted and •	
crack houses and cannabis factories 
closed, targeting those causing the 
greatest harm to communities. Well-
planned, intelligence-led, multi-agency 
Cannabis factories
Intelligence from the community will be used to target 
drug markets and the sources of domestically-produced 
drugs, such as cannabis factories. Cannabis factories 
represent a worrying development. It is clear that serious, 
organised criminals are investing in the production of 
cannabis on a commercial scale. Law enforcement 
agencies report that Vietnamese organised criminal 
groups provide the main sources of cannabis throughout 
England and Wales and this market is well established. 
Cannabis factories are often operated by illegal 
immigrants or trafficked individuals, including children.* 
These factories operate in local communities and all 
agencies, together with local communities themselves, 
must work together to combat this significant threat. 
*  Kapoor, A, 2007, A scoping project on child trafficking in the UK.  
Child Exploitation and Online Protection Centre, London
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operations can have a significant 
sustained impact on the elimination of 
entrenched drug markets.
Drug dealers’ cash and assets seized, •	
demonstrating to communities that 
crime doesn’t pay. We will use all 
available powers and introduce further 
powers to seize the assets of drug 
dealers, stripping them of their visible 
signs of wealth and reinvesting the 
proceeds to benefit communities. 
Preventing harm to communities by 
reducing the supply of drugs into and 
within the country
Our approach to tackling the supply of 
drugs will focus on five key elements:
Tackling the drugs which cause •	
the greatest harm. Class A drugs, 
particularly heroin, cocaine and crack,  
will remain the focus for enforcement. We 
will monitor emerging drug threats such 
as cannabis factories, methamphetamine 
or the misuse of prescription drugs, 
redirecting resources as appropriate. 
Maintaining strong UK border •	
controls. The UK’s border controls are 
a line of defence against drugs entering 
the country. HM Revenue and Customs 
(HMRC) will continue to use intelligence 
and assessments of risk in operating 
these controls. The creation of the UK 
Border Agency, which will bring together 
parts of HMRC and the Border and 
Immigration Agency, will provide better 
integrated border controls. 
 Implementing UK border controls overseas 
can be very effective in reducing trafficking. 
Operations Airbridge and Westbridge, 
joint operations between the UK and the 
governments of Jamaica and Ghana, have 
significantly reduced the number of people 
from those countries swallowing packets 
of drugs to smuggle them into the UK. 
The Government plans to create similar 
partnerships with other governments in key 
countries in the supply chain.
 The Home Office will continue to 
encourage and promote research to 
develop technology to improve detection 
capabilities and lead to more drugs being 
detected that have been concealed on 
or in passengers, in freight and in postal 
packets. 
Expanding international co-operation •	
to further reduce trafficking into the 
UK. We will target the drugs leaving 
producer countries and passing through 
transit countries on their way to the 
UK. SOCA, supported by HMRC and 
the Foreign and Commonwealth Office 
(FCO), will maintain a network of liaison 
officers in priority countries around the 
world whose work will include interrupting 
the supply of drugs to the UK through, 
for example, developing the enforcement 
capabilities of those countries.
 The FCO will continue to help the 
government of Afghanistan implement 
its National Drug Control Strategy, which 
includes a range of activities required to 
combat the drug trade. It is based on 
the successful approaches of Pakistan 
and Thailand, which included a strong 
element of rural development.
  We will develop the value and 
effectiveness of international co-
operation through established multilateral 
organisations, such as the United Nations 
and the European Union, as well as 
through ad hoc multilateral groupings. 
A recent successful example of such 
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co-operation is the establishment of the 
Maritime Analysis and Operation Centre 
– Narcotics (MAOC-N), based in Lisbon. 
This brings together seven countries, 
including the UK, to gather intelligence 
and mount joint operations against 
shipments of cocaine crossing the 
Atlantic. We will extend the involvement 
of the UK in such collaborative efforts 
where they are of clear benefit.
Ensuring closer working between the •	
agencies involved in tackling drug 
supply. Action to tackle drug supply 
within the UK involves the collaboration 
of a range of national and international 
partners and drugs will remain a strategic 
priority for SOCA, working with HMRC 
and the police. SOCA will continue to 
improve identification of the key criminals 
involved in the importation of drugs and 
improve the efficiency of investigations 
and operations against them. Work 
will also continue to identify and target 
drug dealers operating within the UK 
at regional level. A senior cross-agency 
police and law enforcement group 
has been established to ensure a  
co-ordinated operational response 
to drug trafficking.
 The new UK Border Agency will work 
closely with the police to tackle serious 
immigration-related crime, including 
the links between this type of crime 
and drug trafficking. This work will add 
another law enforcement dimension to 
efforts to prevent the supply of drugs 
into and within the country, particularly 
with respect to our efforts to reduce 
the criminality associated with cannabis 
factories.
Street Level Up Approach
The pilot phase of the Street Level Up Approach (SLUA) 
ran for a year from August 2004. The aim was to test how 
multi-agency working can build a comprehensive picture 
of a local drug market, which can inform enforcement 
agencies’ decisions on where intervention would be most 
effective in dismantling and disrupting the supply chain.
The second phase is now being implemented, with 
SLUA being rolled out across a number of police forces. 
It will have a sustained impact on the drug trade and 
drug-related offending and on the harm caused to 
communities by: 
gathering evidence to support the disruption and •	
eradication of criminal businesses at all levels of the 
supply chain;
providing information on the links between drugs and •	
crime;
using innovative tactics, such as financial investigations •	
and asset recovery;
mainstreaming SLUA principles into day-to-day •	
policing; and
identifying and sharing good practice across all forces •	
to maximise outcomes.
Targeting criminal assets.•	  Evidence 
suggests that asset recovery is one 
of the measures which most worries 
criminals at the higher levels of criminal 
networks, such as those involved with 
the importation of drugs. In addition to 
the extension of asset seizure powers 
detailed above, we will enter asset-
sharing agreements with other countries, 
as we have done with the United Arab 
Emirates, allowing the seizure of assets 
sequestered overseas. 
Key strategy actions
Ensure prompt access to treatment for all drug-misusing parents with a treatment need, with •	
parents who are problem drug users and whose children are at risk having rapid access, and all 
assessments taking account of the needs of the family.
Deliver a package of interventions for families at risk, to improve parenting skills, helping parents •	
to educate their children about the risks of drugs, supporting families to stay together and 
breaking the cycle of problems being transferred between generations, drawing on learning from 
innovative programmes and providing intensive interventions where needed.
Support kin carers, such as grandparents caring for the children of substance-misusing parents, •	
by exploring extensions to the circumstances in which local authorities can make payments 
to carers of children classified as ‘in need’, backed up by improved information for carers and 
guidance for local authorities.
Support parents with substance misuse problems so that children do not fall into excessive or •	
inappropriate caring roles.
Meeting our targets
This section of the strategy drives delivery against the 
2008–11 PSA targets relating to:
the proportion of young people frequently using •	
illicit drugs, alcohol or volatile substances (PSA 14); 
and
the number of drug users in effective treatment •	
(PSA 25).
National indicators relating to this section include:
NI110 – young people’s participation in positive •	
activities;
NI111 – first-time entrants to the Youth Justice •	
System aged 10–17;
NI114 – rate of permanent exclusions from school;•	
NI115 – substance misuse by young people; and•	
NI117 – 16–18-year-olds who are not in education, •	
training or employment.
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Street Level Up Approach
The pilot phase of the Street Level Up Approach (SLUA) 
ran for a year from August 2004. The aim was to test how 
multi-agency working can build a comprehensive picture 
of a local drug market, which can inform enforcement 
agencies’ decisions on where intervention would be most 
effective in dismantling and disrupting the supply chain.
The second phase is now being implemented, with 
SLUA being rolled out across a number of police forces. 
It will have a sustained impact on the drug trade and 
drug-related offending and on the harm caused to 
communities by: 
gathering evidence to support the disruption and •	
eradication of criminal businesses at all levels of the 
supply chain;
providing information on the links between drugs and •	
crime;
using innovative tactics, such as financial investigations •	
and asset recovery;
mainstreaming SLUA principles into day-to-day •	
policing; and
identifying and sharing good practice across all forces •	
to maximise outcomes.
Preventing harm to children, young people and 
families affected by drug misuse
Key strategy actions
Ensure prompt access to treatment for all drug-misusing parents with a treatment need, with •	
parents who are problem drug users and whose children are at risk having rapid access, and all 
assessments taking account of the needs of the family.
Deliver a package of interventions for families at risk, to improve parenting skills, helping parents •	
to educate their children about the risks of drugs, supporting families to stay together and 
breaking the cycle of problems being transferred between generations, drawing on learning from 
innovative programmes and providing intensive interventions where needed.
Support kin carers, such as grandparents caring for the children of substance-misusing parents, •	
by exploring extensions to the circumstances in which local authorities can make payments 
to carers of children classified as ‘in need’, backed up by improved information for carers and 
guidance for local authorities.
Support parents with substance misuse problems so that children do not fall into excessive or •	
inappropriate caring roles.
Drug misuse can damage an individual’s 
ability to work, to maintain relationships 
and to care for dependants. Substance 
misuse – whether legal or illegal – can 
have a significant negative impact on the 
development and achievement of young 
people. This not only affects those who use 
drugs, but also their families, their children 
and wider society. 
For young people using and misusing drugs, 
alcohol and volatile substances, harms may 
include:
low educational attainment, truancy or •	
exclusion from school;
involvement in criminal activity and anti-•	
social behaviour which, combined with 
poor educational outcomes, can lead 
to foregone earnings and worklessness, 
lasting well into later life;
greater levels of ill-health or risk-taking •	
behaviour leading to accidents, infection 
Meeting our targets
This section of the strategy drives delivery against the 
2008–11 PSA targets relating to:
the proportion of young people frequently using •	
illicit drugs, alcohol or volatile substances (PSA 14); 
and
the number of drug users in effective treatment •	
(PSA 25).
National indicators relating to this section include:
NI110 – young people’s participation in positive •	
activities;
NI111 – first-time entrants to the Youth Justice •	
System aged 10–17;
NI114 – rate of permanent exclusions from school;•	
NI115 – substance misuse by young people; and•	
NI117 – 16–18-year-olds who are not in education, •	
training or employment.
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estimated in recent research to occur in 
around 60 per cent of cases;
an increased risk of eviction or housing in •	
temporary or unsuitable accommodation;
responsibility for caring for a parent with •	
substance misuse problems, which has 
been shown to lead to a higher incidence 
of educational difficulties; and
a greater risk of experiencing domestic •	
violence or foetal alcohol syndrome 
where a parent is a problematic drinker. 
Since the introduction of the 1998 drug 
strategy, we have seen reductions in young 
people’s drug misuse with, for example, 
sharp falls in the frequent use of drugs by 
vulnerable young people, which fell from 
21 per cent in 2003 to 11 per cent in 2006. 
However, Class A drug use among young 
people aged between 16 and 24 has 
remained relatively stable, falling from 8.6 
per cent in 1998 to 8 per cent in 2006/07.
We know from the available evidence that, 
for young people, there are strong predictive 
Percentage of 16–24-year-olds reporting use of the most prevalent drug types in the last year, 1996 to 2006/07
or pregnancy, with the potential for 
mental health problems and psychosis, 
developmental damage and even 
overdose or death; 
the heavy or frequent use of alcohol or •	
drugs, or progression to heroin or crack 
cocaine use; and
the risk of sexual exploitation.•	
Children of parents who have problems with 
substance misuse can suffer from specific 
harms, which may include:
intergenerational transmission of harms, •	
where substance misusers increase the 
risk that their children will experience 
poor lifetime outcomes or develop 
substance misuse problems themselves;
abuse or neglect, behavioural problems •	
and long-term developmental problems;
exposure to health harms associated with •	
substance-misusing parents, such as 
accidental overdose;
separation from parents, including •	
removal to local authority care, which is 
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factors for the misuse of drugs. These 
allow us to identify those at greatest risk 
of developing substance misuse problems 
and offer them and their families targeted 
preventative support, including:
young people in families at risk, such as •	
those facing multiple disadvantages or 
where parents or siblings misuse drugs 
or alcohol;
young people from specific vulnerable •	
groups, such as those involved in 
offending or anti-social behaviour, 
truants, those excluded from school, or 
those looked after by local authorities;
young people at key transitional •	
stages, such as moving from primary to 
secondary school or on leaving school;
young people subject to specific risk •	
factors, including where their peer group 
have normalised substance misuse or 
where drugs are readily available in the 
area they live in.
We also know more about what works in 
preventing harm to children and young 
people. Specific targeted interventions 
which have been shown to contribute to 
reduced substance misuse and improved 
wider outcomes include:
early intervention targeting those most •	
likely to develop substance misuse 
problems, based on predictive factors 
and routine screening and assessment;
drug and alcohol education programmes •	
delivered by teachers trained to use 
normative, life-skills based approaches, 
and supported by wider communications 
campaigns and by parental and 
community involvement;
interventions and intensive support with •	
at-risk families, to build independent 
living, parenting and monitoring skills 
and to support them to sustain stable 
accommodation;
individually-tailored programmes for •	
specific vulnerable groups, such as 
young offenders; 
reducing absenteeism, developing •	
school-based social work programmes, 
and inclusive school policies to maintain 
engagement with young people who are 
most at risk.
Two strong messages came out of the 
strategy consultation: parents wanted better 
support to educate their children about 
drugs and to know what action to take if 
their child gets involved in drugs; and young 
people were clear that they wanted places 
to go and things to do so that they did not 
start using drugs because there was nothing 
better to do.
Our new approach
Many improvements have been made to 
services for young people, but to make 
a sustainable difference to the challenge 
posed by substance misuse, we must place 
a sharper focus on effective prevention 
and on intervening before problems 
become entrenched. Our new approach 
will emphasise family support, intervening 
earlier with families at risk, such as those 
where children may experience harm as 
a result of parental substance misuse, 
providing targeted youth support for 
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vulnerable young people in all areas and 
providing effective treatment for those 
who do develop problems. We will take a 
whole-family approach, intervening to meet 
the needs of the entire family, involving 
the family in the planning and process of 
treatment, extending family interventions 
and introducing better support for parents to 
access drug treatment. This new approach 
will be based on four key elements.
A new package for families
The Department for Children, Schools and 
Families (DCSF) leads on work to prevent 
substance misuse among young people 
and on family-based interventions. Within 
this work, families will be supported and 
strengthened, so that they can build young 
people’s resilience and reduce the harms 
caused by substance misuse by:
providing better information to parents •	
and other carers to strengthen their role 
in preventing young people’s substance 
misuse; 
where appropriate, involving families in •	
the treatment of young people and other 
family members; and
developing additional support for families •	
at risk, drawing on learning from a range 
of pilot programmes.
Where parental substance misuse exists, 
we will prevent intergenerational harm and 
support access to treatment by:
ensuring that drug-misusing parents •	
have prompt access to treatment, where 
it is required, and that parents who are 
problematic drug users and whose 
children are at risk have rapid access 
to treatment, with assessments taking 
account of family needs;
encouraging the provision of more •	
‘family-friendly’ drug treatment services, 
reducing barriers for those unable to 
engage in treatment due to caring 
responsibilities;
delivering a package of interventions •	
and providing intensive and integrated 
support for families at risk, to improve 
parenting skills, reduce risk factors for 
children, support families to stay together 
and break the cycle of problems being 
transferred between generations, drawing 
on learning from innovative programmes, 
(including Family Intervention Projects, 
Family Drug and Alcohol Courts and 
Family Pathfinders);
supporting kin carers, such as •	
grandparents, who take on care 
responsibilities for the children of 
substance-misusing parents, with 
improved information and support; 
prioritising the protection of children of •	
substance-misusing parents through 
early identification and improved 
information-sharing between children’s 
and adult services;
improving access to additional support •	
services, including help and advice 
with accommodation, employment 
and education, for parents who are 
undergoing treatment; and
addressing pre-natal harms through •	
improved links between maternity and 
treatment services.
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Mainstreaming prevention
We will strengthen the role of mainstream 
provision, in particular schools and children’s 
services, in preventing substance misuse by:
reinforcing the role of schools in delivering •	
effective substance misuse education 
and in identifying young people at risk, 
through the review committed to in the 
Children’s Plan;
supporting directors of children’s services •	
in exercising their local lead on action to 
reduce young people’s substance misuse 
through the delivery of PSA 14, which 
aims to increase the numbers of young 
people on the path to success, with each 
area tailoring prevention activity to meet 
local needs;
ensuring that National Service Framework •	
standards for children, young people and 
maternity services and relevant clinical 
management guidance are applied 
by health service providers to families 
affected by substance misuse;
intervening earlier through mainstream •	
services, such as schools and youth 
services, rather than solely through 
specialist services only once substance 
misuse problems occur;
improving integrated responses for •	
vulnerable young people, through 
Targeted Youth Support, including joined-
up local approaches to related issues, 
such as youth crime, teenage pregnancy 
or those not in education, employment 
or training, supported by improved links 
with the development of the children’s 
workforce;
reducing the availability of substances •	
to young people through policing drug 
supply and through enforcement activity 
on underage sales of cigarettes, alcohol 
and volatile substances; and
improving access to social inclusion •	
programmes, such as Positive Futures 
and the roll-out of Positive Activities, as 
outlined in the ten-year youth strategy, 
Aiming high for young people.
We will also promote activity that helps 
young people to feel like, and to be seen 
as, members of the community. Evidence 
shows that crime and substance misuse are 
lower in cohesive communities where young 
people feel included.
Making improvements to the 
treatment system for young people
The Department for Children, Schools and 
Families has lead responsibility for drug 
treatment for young people, including those 
subject to community sentences, and will 
work with the National Treatment Agency to 
make this treatment more effective by:
developing the workforce, improving •	
access and developing a more outcome-
based approach;
improving transitional arrangements for •	
those transferring from young people’s to 
adult services; 
strengthening links between young •	
people’s treatment and mental health 
services;
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Meeting our targets
This section of the strategy drives delivery against the 
2008–11 PSA targets relating to:
the number of drug users in effective treatment •	
(PSA 25).
National indicators relating to this section include:
NI40 – drug users in effective treatment;•	
NI120 – all-age all-cause mortality rate;•	
NI141 – number of vulnerable people achieving •	
independent living;
NI143, 145, 147, 149 – socially excluded adults •	
living in settled and suitable accommodation; 
NI144, 146, 148, 150 – socially excluded adults in •	
employment, education or training; and
NI152 – working-age people on out-of-work benefits.•	
Key strategy actions
Develop pilots to test new approaches which can provide better end-to-end management •	
through the system, including a more effective use of pooled funding and individual budgets, and 
with a sharper focus on outcomes. 
Develop a package of support to help drug users, and particularly those causing the most harm, •	
to access and complete treatment and to re-integrate into society.
Use opportunities presented by the benefits system to provide support and create incentives to •	
move towards treatment, training and employment.
Ensure treatment is personalised and outcome-focused, making full use of new treatment •	
approaches that are shown to be effective.
Draw on significant new funding to support research into developing better forms of treatment.•	
ensuring a seamless transition from •	
the secure estate to community-based 
treatment services, including the 
provision of support to aid resettlement, 
learning lessons from Resettlement 
Aftercare Provision (RAP); and
supporting and involving young people •	
and their parents and carers more in the 
planning and process of treatment for 
young people, and involving carers’ and 
users’ groups in the design and planning 
of treatment services. Where no such 
groups exist, we will encourage local 
areas to establish them. 
Building our evidence base of 
what works 
We will continue to build the evidence 
base and develop our understanding 
of the factors affecting young people’s 
substance misuse, the harms experienced 
and the most effective interventions in 
education, prevention and treatment. We 
will also review the impacts of family-based 
interventions working with families at risk 
of substance misuse. A review of the key 
gaps in the evidence base will inform the 
planning of a cross-government research 
programme.
Drugs in sport
Doping undermines the integrity of sport. Sport can be 
a positive activity for children and young people and can 
provide alternatives to risky behaviour that can lead to 
drug misuse and, for many young people, athletes are 
seen as role models. 
As we approach London 2012 and beyond to the 
Glasgow Commonwealth Games in 2014, there will be 
increasing international focus on our anti-doping policies 
and programmes. We are committed to protecting our 
athletes from the impact of trafficking, supply and the 
manufacture of prohibited substances. The Government 
will work with key agencies, including the National Anti-
Doping Organisation, to respond robustly to those who 
tarnish our national image by cheating in sport.  
To do this we will ensure that we strengthen the 
mechanisms in place to: 
tackle doping in sport;•	
target those facilitating doping;•	
tackle trafficking, supply and manufacture of doping •	
substances, and those involved in such activities.
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Meeting our targets
This section of the strategy drives delivery against the 
2008–11 PSA targets relating to:
the number of drug users in effective treatment •	
(PSA 25).
National indicators relating to this section include:
NI40 – drug users in effective treatment;•	
NI120 – all-age all-cause mortality rate;•	
NI141 – number of vulnerable people achieving •	
independent living;
NI143, 145, 147, 149 – socially excluded adults •	
living in settled and suitable accommodation; 
NI144, 146, 148, 150 – socially excluded adults in •	
employment, education or training; and
NI152 – working-age people on out-of-work benefits.•	
 
Delivering new approaches to drug treatment and 
social re-integration
Key strategy actions
Develop pilots to test new approaches which can provide better end-to-end management •	
through the system, including a more effective use of pooled funding and individual budgets, and 
with a sharper focus on outcomes. 
Develop a package of support to help drug users, and particularly those causing the most harm, •	
to access and complete treatment and to re-integrate into society.
Use opportunities presented by the benefits system to provide support and create incentives to •	
move towards treatment, training and employment.
Ensure treatment is personalised and outcome-focused, making full use of new treatment •	
approaches that are shown to be effective.
Draw on significant new funding to support research into developing better forms of treatment.•	
In addition to the crime harms associated 
with drug dependency, drug use causes 
a wide range of health and social harms. 
It causes short and long-term damage to 
physical and mental health, it affects unborn 
babies and it exposes drug users to risk 
of death from overdose and blood-borne 
viruses. This in turn creates wider public 
health risks caused by discarded drug 
paraphernalia, drug driving or infections 
caused by unprotected sex with an 
intravenous drug user. Drug use also limits 
the ability to work, to parent and to function 
effectively in society. It contributes to social 
exclusion and makes it difficult for people to 
play full and active roles in society. 
To address these harms, the Government’s 
1998 drug strategy established the National 
Treatment Agency and introduced significant 
increases in investment in drug treatment, 
Drugs in sport
Doping undermines the integrity of sport. Sport can be 
a positive activity for children and young people and can 
provide alternatives to risky behaviour that can lead to 
drug misuse and, for many young people, athletes are 
seen as role models. 
As we approach London 2012 and beyond to the 
Glasgow Commonwealth Games in 2014, there will be 
increasing international focus on our anti-doping policies 
and programmes. We are committed to protecting our 
athletes from the impact of trafficking, supply and the 
manufacture of prohibited substances. The Government 
will work with key agencies, including the National Anti-
Doping Organisation, to respond robustly to those who 
tarnish our national image by cheating in sport.  
To do this we will ensure that we strengthen the 
mechanisms in place to: 
tackle doping in sport;•	
target those facilitating doping;•	
tackle trafficking, supply and manufacture of doping •	
substances, and those involved in such activities.
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with a particular focus on helping as many 
drug users as possible to access treatment. 
This has delivered significant benefits: 
More people are receiving treatment, with •	
the number in contact with treatment 
services increasing from 85,000 in 1998 
to 195,000 by 2006/07 with the target 
to double the numbers in treatment 
achieved two years early.
Three-quarters of new entrants to •	
treatment are now retained in treatment 
for 12 weeks or more, which is the 
minimum period that can have a lasting 
impact on entrenched drug use.
The average national waiting time for •	
drug treatment has been reduced from 
nine weeks to less than two and a half 
weeks.
The steep and continuing rises in •	
the rates of drug-related deaths that 
occurred throughout the 1990s have now 
been halted.
A new qualifications framework and suite •	
of occupational standards is improving the 
professional skills of treatment workers.
Our new approach
The goal of all treatment is for drug users 
to achieve abstinence from their drug – or 
drugs – of dependency. For some, this can 
be achieved immediately, but many others 
will need a period of drug-assisted treatment 
with prescribed medication first. Drug 
users receiving drug-assisted treatment 
should experience a rapid improvement 
in their overall health and their ability to 
Numbers entering drug treatment 1998–2006/07
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Note on methodology 
In 2005, the National Treatment Agency commissioned the National Drug Evidence Centre, University of Manchester, to re-
examine the baseline for the number of people in drug misuse treatment in 1998/99. This revision in the baseline was quality 
assured by the Office for National Statistics and had approval from the then Home Secretary, Charles Clarke. The estimated 
figures above are a projected trajectory from an adjusted baseline of 85,000 in treatment in 1998/99.  
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work, participate in training or support 
their families. They will then be supported 
in trying to achieve abstinence as soon as 
they can.
While large numbers are entering drug 
treatment, with most deriving significant 
benefit from it, too many drug users relapse, 
do not complete treatment programmes, 
or stay in treatment for too long before 
re-establishing their lives. The challenge for 
the new strategy is to maximise the impact 
of treatment for those who receive it, seizing 
the opportunity treatment provides to reduce 
the harms caused to communities, families 
and individuals. We will therefore work to 
develop more personalised approaches to 
treatment services, which have the flexibility 
to respond to individual circumstances. We 
will examine how we can best support those 
leaving and planning to leave treatment with 
packages of support to access housing, 
education, training and employment. We will 
deliver better outcomes, with more people 
becoming re-integrated into society, through 
a focus on four key objectives.
Targeting those most at risk
The Department of Health has lead 
responsibility for delivering effective drug 
treatment and will continue to prioritise 
heroin and crack use, while improving 
access for under-represented groups and 
those with complex needs by:
addressing unmet treatment needs and •	
barriers to treatment, which may include 
the needs of young people, women, 
crack or poly-drug users, particular black 
and ethnic or other minority communities, 
sex workers or parents with dependent 
children;
removing barriers to accessing services •	
for users with children, and acting 
promptly to protect children where they 
are found to be at risk;
targeting services for those with complex •	
needs, such as drug users with mental 
health problems; and
prioritising access to treatment for those •	
drug-misusing offenders who enter 
through DIP and those leaving prison 
or completing the DRR of a community 
sentence or a period on licence.
Improving the quality and 
effectiveness of treatment
We will achieve better outcomes for those 
entering treatment by:
improving retention of clients in •	
treatment, with more clients overcoming 
drug dependence and successfully 
completing treatment programmes and 
re-integrating into communities;
driving up standards across all •	
treatment providers through new local 
clinical governance arrangements and 
by monitoring a range of treatment 
outcomes, including re-offending, 
employment and health; 
improving, where appropriate, the sharing •	
of information between agencies to 
facilitate the management of clients;
continuing to promote harm minimisation •	
measures including needle exchange and 
drug-assisted treatments that encourage 
drug users to enter treatment, in order 
to reduce the risk of overdose for drug 
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users and the risk of infection for the 
wider community; and
improving commissioning skills and •	
continuing to engage service users in 
the planning and delivery of services at 
a local level, to ensure that services are 
responsive to local needs.
A wider use of new treatment 
approaches
We will build on new evidence of what  
works and maximise the range of 
approaches used, including by:
using contingency management pilots, in •	
which positive reinforcement techniques 
are used to encourage clients to maintain 
a course of treatment, to identify and 
reinforce good practice and address 
concerns about the inappropriate use of 
rewards in treatment;
encouraging clients and family members •	
to make wider use of mutual aid 
support networks, such as abstinence 
programmes and local support groups, 
to improve treatment outcomes; 
developing and delivering a significant •	
new initiative to support research that 
will boost our understanding of addiction 
and identify opportunities for new forms 
of treatment or prevention. Building on 
the major expansion of health research 
funding from the last Spending Review, 
the Medical Research Council and the 
National Institute for Health Research 
have agreed that addiction should be 
one of the joint priority areas for health 
research funding, led by the Medical 
Research Council; 
applying learning about what works •	
gathered through the routine monitoring 
of treatment outcomes through, for 
example, the National Drug Treatment 
Monitoring System; and
rolling out the prescription of injectable •	
heroin and methadone to clients who do 
not respond to other forms of treatment, 
subject to the findings, due in 2009, of 
pilots exploring the use of this type of 
treatment.
A radical new focus on services 
to help drug users to re-establish 
their lives
The ambition of this strategy is to achieve 
sustainable reductions in the harms caused 
by drugs. Drug problems do not occur in 
isolation, and may be both the cause and the 
consequence of wider social and personal 
problems. The Government’s programmes to 
tackle social exclusion among adults and at-
risk families recognise that people or places 
can become trapped in a cycle of related 
problems, such as unemployment, poor 
skills, low incomes, poverty, poor housing, 
high crime, bad health and family breakdown 
– all factors which can be related to higher 
levels of drug use. 
In order to address the wider problems 
faced by those affected by drugs, we will 
link this strategy with the framework set out 
in Reaching Out: An Action Plan on Social 
Exclusion and the Families at Risk Review and 
we will draw on the Adults Facing Chronic 
Exclusion Programme as part of a package 
of action, social care and support to help 
individuals and families to re-integrate and re-
establish themselves in the community. 
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We will also make full use of the Working 
Neighbourhoods Fund, a £1.5 billion 
contribution to the Area Based Grant 
launched in November 2007 to help local 
authority areas facing some of the greatest 
challenges in terms of worklessness and low 
levels of skills and enterprise. The Working 
Neighbourhoods Fund has been allocated to 
87 local authority areas for the period from 
2008 to 2011.
For drug misusers, the Department 
of Health, the Department for Work 
and Pensions and the Department for 
Communities and Local Government will 
take the lead on work to support drug 
misusers’ re-integration into society by:
encouraging joint working between •	
treatment agencies, Jobcentres and 
sources of housing advocacy and advice, 
to plan and manage clients’ journeys 
through treatment and into work, helping 
them access the wider support they need 
to re-establish their lives; 
encouraging local authorities to work •	
with partners to meet locally-identified 
need for housing and support for those 
affected by drug misuse;
allowing the Pooled Treatment Budget to •	
be used alongside other funding streams 
to provide advice on re-integration 
support and case management;
ensuring that all local partners are aware •	
of the need to assess the wider needs 
of drug misusers and those in treatment; 
and
A new approach to delivering services 
– pilot project
Existing drug funding, commissioning and delivery 
systems have helped to deliver an unprecedented 
increase in drug treatment, but they are complex and 
characterised by a multitude of rules, funding streams, 
commissioning and process targets. This can result in a 
‘one-size-fits-all’ service with limited choice in the type of 
treatment and broader social support available. Over time, 
we need to ensure the drug treatment system and these 
services work more closely together and become more 
focused on improving outcomes, which could include a 
more personalised and innovative service. Therefore, we 
will develop pilots to test a variety of new approaches 
at the strategic level, relating to relationships between 
central and local government, and at the delivery level, 
to provide more end-to-end management through the 
system, with more reliance on local outcome targets. The 
pilots will also include the use of individual budgets, held 
by drug workers rather than the user, which can be used 
to personalise interventions in a more flexible way.
exploring the potential, initially through •	
pilot projects, of the use of pooled 
budgets, end-to-end case management 
and individual budgets linking treatment 
benefits, training and employment 
support, with a focus on achieving 
positive outcomes for clients. 
The benefits system must support our new 
focus on re-integration and personalisation. 
In order to ensure that it provides the right 
level of support and creates incentives for 
people with drug problems to move towards 
treatment, training and employment, we will 
at a minimum:
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Meeting our targets
This section of the strategy drives delivery against the 
2008–11 PSA targets relating to:
the proportion of young people frequently using •	
illicit drugs, alcohol or volatile substances (PSA 14); 
and
the percentage of the public who perceive drug use •	
or dealing to be a problem in their area (PSA 25).
Key strategy actions
Extend the use of FRANK to provide access to support and interventions, to support local •	
campaigns and school-based education, and to target key audiences.
Improved support and information for parents. We will bring together a partnership of leading •	
organisations pledging to support and provide information for parents.
Develop better community-based communications to build community confidence and •	
engagement in the work being done to tackle drug misuse.
require drug misusers on out-of-work •	
benefits to attend a discussion with an 
appropriate specialist treatment provider 
or partner organisation as part of the 
Jobseeker Direction or Work Focused 
Interview requirements; and 
encourage closer links between relevant •	
agencies so that drug misusers who 
are claiming benefits can be referred to 
specialist services.
These changes are a first step in helping 
clients to overcome barriers to work and 
ensuring Jobcentre Plus engages more 
closely with local drug partnerships and 
treatment providers in all areas where this 
is not already happening. 
However, we do not think it is right for the 
taxpayer to help sustain drug habits when 
individuals could be getting treatment to 
overcome barriers to employment. So, we 
will explore the case for introducing a new 
regime for drug misusers which provides 
more tailored and personalised support 
than is currently provided by the existing 
Incapacity Benefit or Jobseeker Allowance 
regimes. In return for benefit payments, 
claimants will have a responsibility to move 
successfully through treatment and into 
employment. Further proposals will be 
announced regarding these measures. 
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Meeting our targets
This section of the strategy drives delivery against the 
2008–11 PSA targets relating to:
the proportion of young people frequently using •	
illicit drugs, alcohol or volatile substances (PSA 14); 
and
the percentage of the public who perceive drug use •	
or dealing to be a problem in their area (PSA 25).
Public information campaigns, communications and 
community engagement
Key strategy actions
Extend the use of FRANK to provide access to support and interventions, to support local •	
campaigns and school-based education, and to target key audiences.
Improved support and information for parents. We will bring together a partnership of leading •	
organisations pledging to support and provide information for parents.
Develop better community-based communications to build community confidence and •	
engagement in the work being done to tackle drug misuse.
Communications have a key role to 
play in addressing the harms caused by 
drugs, but present unique challenges. 
Communications compete in a crowded 
media space, vying for the attention of a 
range of target audiences and competing 
against misleading sources of information. 
Communications activity needs to transmit 
clear information and advice, often in 
opposition to sometimes contradictory 
media messages. 
Young people need credible, balanced 
information about the risks posed 
by drugs, which complements drug 
education delivered in school and other 
settings. Parents need information to build 
knowledge, to provide reassurance and to 
develop the confidence to address drug use 
issues within the family. Communication also 
plays a key role in the community, providing 
reassurance and strengthening confidence 
and resilience, where communities are 
aware of the action that is being taken to 
tackle drug dealing and drug-related crime. 
Our knowledge of what works in 
communications has developed substantially 
since the publication of the 1998 strategy. 
We are now offering credible and well-
used drug advice and information, using 
the kinds of media most used by the target 
audience, including the internet, magazines 
and social networking sites. As an example, 
FRANK has become established as a 
widely recognised and trusted helpline and 
website, and its advertising and related 
activity has brought about a shift in young 
people’s attitudes to drugs, with more 
perceiving drugs negatively. Following a 
FRANK multi-media cannabis campaign, 
research showed there was a 12 per cent 
increase in the number of young people 
agreeing with the statement that ‘cannabis 
can damage the mind of someone who uses 
it’, and 89 per cent reported that they knew 
about FRANK and what its purpose was.
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We know that:
campaigns are effective at reinforcing •	
existing non-drug using behaviours and 
attitudes and at dispelling inaccurate 
perceptions of the harms posed by 
individual drugs;
campaigns can increase the uptake of •	
drug treatment, encourage safer drug 
use and achieve greater professional and 
public support for drug programmes; and
information can increase parents’ •	
confidence in making a positive 
contribution to preventing drug use 
and changing young people’s attitudes 
towards drug use. 
Our new approach
Young people and families
DCSF, the Home Office and the 
Department of Health lead on the delivery 
of communications campaigns and activity 
targeted on young people and families.
We will bring together a partnership •	
of leading young people’s and 
parents’ organisations to engage and 
communicate with parents. They will 
find out what more information and 
support can be provided to parents and 
will recommend ways in which families 
and parents can be called on to tackle 
this issue. 
The Government will target parents – •	
particularly those whose children may 
be at increased risk – to give them 
the facts about drugs and their use. 
We will increase the knowledge and 
understanding of drugs, enabling parents 
to have a positive influence over their 
children in an informed and credible 
way. DCSF will explore the feasibility of 
combining messages to parents across a 
range of issues.
We remain committed to the FRANK •	
campaign, which will use a mix of media 
and technologies to talk to young people 
about the risks and effects of drug use. 
Local partnerships will receive support 
and encouragement to run local drug 
awareness campaigns with links to 
FRANK where appropriate.
The difference communications will 
make to the public:
We will reach parents across the •	
country with information on drugs to 
give them the confidence and know-
how to talk to their children about this 
issue and understand where to get help.
Increased FRANK communications will •	
raise awareness among young people 
of the dangers of drugs.
A leaflet will be available to every •	
community on what the new drug 
strategy means for them.
In areas where drug misuse is a •	
significant problem and a priority for 
local people, visible policing teams 
will be taking action and engaging the 
community.
Communities will see benefits as a •	
result of increased visible enforcement 
activity to crack down on drug dealers 
and to increase the seizure of criminal 
assets.
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In line with the Government’s alcohol •	
strategy, Safe. Sensible. Social., we 
will commission strategic research 
with young people and stakeholders to 
develop an evidence base for a campaign 
targeting under-18s about alcohol. 
Following completion of the DCSF review •	
of drug education, FRANK activity will be 
developed to complement wider drug 
education objectives.
FRANK will become a portal for young •	
people to access the drug treatment 
or targeted support that they need. For 
young cannabis users who wish to stop 
or cut down their use, FRANK will offer a 
supported online programme based on 
successful models in the Netherlands.
Communities
The Home Office and partner agencies 
have lead responsibility for effective 
communications to make communities safer. 
We will develop wider communications •	
for communities affected by drug-
related crime. With the roll-out of the 
Neighbourhood Policing approach, we 
will ensure that communities know how 
to report drug-related crime and what will 
be done to tackle it. 
We will also work with local agencies to •	
bring about a reduction in the percentage 
of the public who perceive drug use 
and dealing to be a problem in their 
area. Local partnerships have a role 
to play in informing and reassuring the 
communities they serve that drug use 
and dealing is being tackled. We will 
support and champion the roll-out of 
local campaigns such as ‘Rat on a Rat’, 
which maximise community intelligence, 
identify drug dealers and disrupt drug 
markets.
The public will be made aware that •	
assets seized from drug traffickers will be 
invested back into their community.
National communications platforms •	
including National Tackling Drugs 
Week in May and the Tackling Drugs, 
Changing Lives Awards will ensure that 
communities are fully informed and 
engaged in work being done locally to 
make their communities drug-free. The 
Government will also work with national 
and local role models to bring to life the 
difference being made across the country.
By sharing with the community the •	
positive outcomes achieved for 
drug misusers through a range of 
interventions, we will demonstrate the 
effectiveness of coherent interventions 
and the role of the community in 
supporting those outcomes.
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Drug driving – communicating safety messages
Drug driving is reported to be an increasing problem. 
A Department for Transport (DfT) research study published 
in 2000 found traces of illegal drugs in the bodies of 18 per 
cent and medicinal drugs in 6 per cent of the road fatalities 
in the study, a substantial increase from data reported ten 
years previously. However, the study was unable to establish 
the victims’ level of impairment.
Enforcement methods are improving, with police officers 
being trained to make arrests that can lead to convictions. 
Severe penalties – with disqualification for at least 12 months 
– are imposed on those convicted.
Publicity and education are central to changing perceptions 
of the dangers posed by driving under the influence of 
drugs, and these are channelled towards groups who 
are more likely to take drugs. The DfT campaign targets 
young drivers and passengers who are planning nights out, 
and who might be tempted to drive or accept lifts. During 
the summer music festival period and in the build-up to 
Christmas and New Year, a range of media, including an 
information website, aim to persuade drug users of the risks 
associated with driving under the influence of drugs. To 
date, these have proved effective in raising awareness of the 
issue and are seen by the target groups as an appropriate 
intervention. 
To support enforcement and education activities, DfT will 
begin a consultation process to establish whether the 
current process of police enforcement for drug impairment 
could be made more effective.
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The delivery of the strategy will reflect the 
devolution of powers to the Assemblies 
in Wales and Northern Ireland and the 
Parliament in Scotland. The UK Government 
is responsible for setting the overall 
strategy and for its delivery in the devolved 
administrations only in the areas where it 
has reserved power. Thus, the scope of the 
strategy is that:
Devolved powers
health, education, housing and social •	
care are confined to England;
policing and the criminal justice system, •	
including all aspects of offender 
management, cover England and Wales;
the work of the Department for Work and •	
Pensions applies to England, Wales and 
Scotland; and
the work of SOCA and HMRC to address •	
drug supply covers the UK.
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Appendix 1
Delivery mechanisms
To continue to drive progress in 
preventing and tackling the harms caused 
by drugs, delivery of the drug strategy 
needs to be firmly embedded within the 
mainstream delivery frameworks of all 
partners. Many drug-specific delivery 
structures have been developed and have 
provided focus at national, regional and 
local levels. To build on the achievements 
of the previous strategy and to bridge 
some of the delivery gaps highlighted 
by the strategy consultation process, 
we must now ensure that action to 
tackle substance misuse is at the core 
of national, regional and local planning 
and delivery processes in all departments 
and agencies that have a role to play in 
delivering the drug strategy.
the Department for Innovation, •	
Universities and Skills;
the Foreign and Commonwealth Office; •	
and
the Department for International •	
Development.
A range of agencies within the delivery 
structures of government departments are 
more directly involved with delivering the 
drug strategy. These include the Serious 
Organised Crime Agency, the UK Border 
Agency and the National Treatment Agency 
for Substance Misuse.
Indicators relating to the delivery of the 
drug strategy and the related PSAs are 
embedded within the Local Government 
Performance Framework, the Assessments 
of Policing and Community Safety 
framework, and the Department of Health 
performance framework, and in the 
frameworks of other key partners, such as 
the National Offender Management Service 
and the Youth Justice Board.
At a national level, policy and delivery are 
the responsibility of a number of central 
government departments. For the period 
2008–11, the departments with ownership 
of Public Service Agreement (PSA) targets 
directly relating to drugs and alcohol are: 
the Home Office (PSA 25);•	
the Department of Health (PSA 25); and•	
the Department for Children, Schools and •	
Families (PSA 14).
Other departments with a significant role to 
play in the delivery of the strategy include:
the Ministry of Justice;•	
HM Revenue and Customs;•	
the Department for Communities and •	
Local Government;
the Department for Work and Pensions; •	
PSA 25
Reduce the 
harm caused 
by alcohol and 
drugs
•  The number of drug users in 
effective treatment.
•  The rate of drug-related 
offending.
•  The percentage of the public 
who perceive drug use or 
dealing to be a problem in 
their area.
PSA 14
Increase the 
number of 
children and 
young people 
on the path to 
success
•  The proportion of young 
people frequently using illicit 
drugs, alcohol or volatile 
substances.
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The key indicators which demonstrate 
performance against current PSA targets 
include:
the level of drug-related offending •	
(PSA 25);
the number of drug users in effective •	
treatment (PSA 25);
community perceptions of drug use or •	
drug dealing as a problem (PSA 25); and
levels of substance misuse among young •	
people (PSA 14).
There are many additional indicators which 
support delivery of the strategy, including:
Outcome National indicators PSA LAA 
indicator
Safer communities Serious violent crime rate 23 NI15
Serious acquisitive crime rate NI16
Perceptions of anti-social behaviour NI17
Adult re-offending rates for those under probation 
supervision
NI18
Rate of proven re-offending by young offenders NI19
Dealing with local concerns about anti-social behaviour 
and crime by the local council and police
NI21
Re-offending rate of prolific and priority offenders NI30
Children and young 
people
Young people’s participation in positive activities 14 NI110
First-time entrants to the Youth Justice System aged 10–17 NI111
Rate of permanent exclusions from school NI114
16–18-year-olds who are not in education, training or 
employment
NI117
Adult health and 
wellbeing
All-age all-cause mortality rate 18 NI120
Tackling exclusion 
and promoting 
equality
Proportion of socially excluded adults (offenders under 
probation supervision, adults with learning disabilities, 
care leavers and adults in contact with secondary mental 
health services) in settled accommodation
16 NI143 
NI145 
NI147 
NI149
Proportion of socially excluded adults (offenders under 
probation supervision, adults with learning disabilities, 
care leavers and adults in contact with secondary mental 
health services) in employment, education or training
NI144 
NI146 
NI148 
NI150
Local economy Working-age people on out-of-work benefits 8 NI152
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Local authorities and their partners will 
continue to make a significant contribution 
to tackling the harm caused by illegal drugs. 
From June 2008, Local Area Agreements 
(LAAs) will be the mechanism by which 
central government will set improvement 
targets for outcomes to be delivered – 
either alone or in partnership – through 
local government in England. These targets 
are selected from a single set of national 
indicators for local authorities and their 
partners. Primary Care Trusts will also 
be required to report to Strategic Health 
Authorities on progress against national 
priorities relevant to the drug strategy which 
are within Vital Signs, the NHS operating 
framework. 
The Comprehensive Area Assessment 
(CAA), which will be introduced from 2009, 
will assess the likelihood of a local area 
achieving the targets for improvement 
identified in their LAA and will identify 
barriers to that improvement. The focus 
of the CAA will not, however, be restricted 
to the LAA, and will reflect inspectorates’ 
assessments of, for example, the quality of 
engagement with local communities or the 
degree to which risks to people in vulnerable 
circumstances are being addressed. Further 
information on the new local government 
performance framework can be found at 
www.communities.gov.uk/localgovernment/
performanceframeworkpartnerships/. 
There is a very strong and reciprocal 
relationship between drug misuse and 
related issues, such as crime, anti-social 
behaviour and social exclusion. Any action 
to tackle the prevalence or severity of any 
related issue will help to address drug 
misuse. Action to address drug misuse will 
also have an impact on related issues, such 
as the level of crime.
The reciprocal nature of this relationship 
supports the embedding of responses to 
drug misuse within the agendas of delivery 
partners. This mainstreaming process is 
essential to establish and maintain a long-
term and sustainable response to drug 
misuse, and the process is supported by 
the new local government performance 
framework. While it is unlikely that any 
local area will select all of the drug-specific 
indicators within its LAA improvement 
targets, it is also extremely unlikely that 
any area will not select any of the related 
indicators and, therefore, in taking measures 
to improve performance against those 
indicators, will deliver improvements in 
relation to drug misuse. 
At a regional level, Government Offices 
will work with top-tier Local Strategic 
Partnerships, Crime and Disorder Reduction 
Partnerships and Drug (and Alcohol) Action 
Teams to provide them with the support 
to ensure that their internal structures 
are robust and that all relevant partners 
are appropriately involved in both the 
partnership and in LAA negotiations. This 
will include helping local authorities and 
partners in their negotiation of improvement 
targets in LAAs, reviewing progress and, 
where necessary, co-ordinating action to 
respond to underperformance. Government 
Offices will identify and share good practice 
and will work with regional partners to 
support delivery. Key regional partners 
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include Regional Offender Managers, the 
Youth Justice Board, the National Treatment 
Agency, Strategic Health Authorities and 
Regional Improvement and Efficiency 
Partnerships. 
At a local level, local partnerships – 
whether Drug Action Teams or crime and 
drugs partnerships – played a critical role 
in delivering the previous drug strategy. 
To build on the progress that has been 
made through this enhanced focus, we need 
to examine whether further improvements 
could be made through a greater integration 
of drug issues within the wider local delivery 
framework. This would ensure that provision 
for tackling substance misuse forms part of 
the core planning and delivery arrangements 
within a local area. The National Audit Office 
will carry out a study to evaluate the cost-
effectiveness of Drug Action Teams and to 
identify where efficiencies and improvements 
might be made.
Local Strategic Partnerships, through their 
role in developing Sustainable Community 
Strategies and LAAs, will have overarching 
responsibility at local level for delivering 
the strategy, supported by other local 
partnerships, which will include Drug Action 
Teams, Crime and Disorder Reduction 
Partnerships (or merged crime and drugs 
partnerships), local Criminal Justice 
Boards and local Safeguarding Children 
Boards. It should be noted that Crime and 
Disorder Reduction Partnerships have a 
specific statutory responsibility with regard 
to substance misuse. Where Crime and 
Disorder Reduction Partnerships and drugs 
partnerships are not merged there needs 
to be effective joint working between the 
partnerships. The precise local delivery 
arrangements should be determined by 
individual areas in accordance with local 
needs and structures. 
National Audit Office study
The National Audit Office will conduct a study to 
evaluate the effectiveness and value-for-money of Drug 
Action Teams (DATs), by examining costs and outcomes 
achieved. The study will aim to:
identify examples of good practice and examine the •	
risks to the delivery of objectives;
examine trends in funding against the timing of •	
funding announcements, to identify the effect on 
planning and commissioning;
examine the variability in demands for services and •	
the deployment of funds across all DATs;
examine collated performance reports against key •	
performance targets;
determine the costs of performance monitoring and •	
reporting and the robustness and constraints of such 
reporting mechanisms; and
take follow-up action on the success factors, •	
conclusion and recommendations made in the 
2004 Audit Commission report Drug Misuse 2004: 
Reducing the local impact.
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Appendix 2
Legislative framework
A detailed framework of legislation 
underpins the Government’s approach 
to tackling the harms caused by drug 
misuse. This framework helps determine 
the priorities of the police and other law 
enforcement agencies, and directs the 
judiciary’s sentencing practices. 
The key piece of legislation is the Misuse 
of Drugs Act 1971 and its Regulations. 
The 1971 Act identifies those drugs that are 
‘dangerous or otherwise harmful’ – referred 
to as ‘controlled drugs’ – and proscribes 
their unlawful possession, supply and 
production. Controlled drugs are classified 
in one of three categories – Class A, B 
or C – according to how harmful they are 
considered to be either to the individual  
or to society more generally. 
The following refers to other relevant 
legislation but is not exhaustive: 
the •	 Medicines Act 1968, which 
governs the manufacture and supply 
of medicines; 
the •	 Bail Act 1976 (as amended by 
the Criminal Justice Act 2003), which 
provides for a restriction on court bail 
for Class A drug users;
the •	 Customs and Excise Management 
Act 1979, which together with the 
1971 Act proscribes the unauthorised 
importation or exportation of controlled 
drugs;
the •	 Police and Criminal Evidence Act 
1984 (as amended by the Drugs Act 
2005), which provides for persons in 
police detention to be tested for specified 
Class A drugs on arrest/after charge;
the •	 Road Traffic Act 1988, which makes 
it an offence to drive, attempt to drive 
or be in charge of a vehicle on a road or 
public place when unfit (‘ability impaired’) 
to drive through drink or drugs; 
the •	 Proceeds of Crime Act 2002, 
which provides powers to confiscate 
the property of those convicted of drug 
trafficking;
the •	 Anti-Social Behaviour Act 2003, 
which gives the power for courts in 
England and Wales to issue orders for 
the closure of premises where Class A 
drugs and serious nuisance or disorder 
are a problem; 
the •	 Criminal Justice Act 2003, which 
enables courts to impose a drug 
rehabilitation requirement as part of a 
Community Order (replacing the Drug 
Treatment and Testing Order originally 
introduced by the Crime and Disorder Act 
1998); and
the •	 Drugs Act 2005, which provides 
for assessments by a drug worker 
of those testing positive for specified 
Class A drugs and amended the Crime 
and Disorder Act 1998 to allow for 
intervention orders to be attached to 
Anti-Social Behaviour Orders issued to 
adults where behaviour is drug-related. 
Three United Nations Conventions (on 
narcotic drugs in 1961, on psychotropic 
substances in 1971, and against trafficking 
in narcotic drugs and psychotropic 
substances in 1988) provide the international 
legal framework for the prevention of drug 
misuse and trafficking.
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Appendix 3
Diversity and equality
Success in meeting our objectives depends 
upon achieving the best outcomes for all 
members of all communities, and upon 
anticipating and meeting the specific 
needs that any group may have. It is of 
central importance that we consider what 
is meant by diversity and how it applies to 
everything that we do. 
Key legislation relating to diversity includes:
The Race Relations (Amendment) •	
Act 2000, which amends the 1976 Act 
prohibiting race discrimination by placing 
a duty on public authorities (or bodies 
providing public services) to eliminate 
race discrimination, promote equality of 
opportunity, promote good relations and 
have systems in place to meet these 
obligations.
The Sex Discrimination Act 1975 (as •	
amended) prohibits discrimination on 
the basis of sex and places a duty on 
public authorities to proactively promote 
equality. It is permissible for a service 
to be delivered separately for either sex 
where this is the most effective way for 
the service to be delivered, as in the 
case of a refuge for victims of domestic 
violence.
The Disability Discrimination Act 1995 •	
(as amended) offers similar protection 
to people with disabilities as are offered 
under the Acts described above. It also 
places similar obligations with regard 
to people with disabilities on public 
authorities or private bodies delivering 
public services.
The Equality Act 2006•	  outlaws 
discrimination on the basis of religion 
or sexual orientation in the provision 
of goods, facilities and services. 
It complements the Employment 
Equality (Religion or Belief) Regulations 
2003 and the Employment Equality 
(Sexual Orientation) Regulations 2003, 
which make it unlawful to discriminate in 
employment on the basis of, respectively, 
religion or sexual orientation. 
Other legislation which, while not being 
directly relevant to the drug strategy, may 
have an impact on the agencies involved in 
its delivery, includes:
The Gender Recognition Act 2004;•	
The Sex Discrimination (Gender •	
Reassignment) Regulations 1999;
The Equal Pay Act 1970 (as amended); •	
and
The Civil Partnership Act 2004.•	
The Home Office Diversity Manual contains 
more detailed information on diversity 
legislation, along with guidance and sources 
of further information. The Government 
will update this source of information, 
drawing on examples of best practice from 
across the sector, and highlighting the 
responsibilities that local areas have to meet 
the needs of their local communities. 
Local planning and delivery
Local areas are responsible for meeting 
the needs of all communities and should 
be aware that the provision of universally 
available services does not necessarily, 
by itself, meet those needs. For example, 
members of particular groups may be 
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culturally inhibited from approaching 
mainstream drug services and may, as 
a result, suffer discrimination. Service 
providers have a duty to proactively tackle 
such discrimination. 
For many areas, existing sources of 
information will be insufficient for the 
effective planning of services to meet 
community needs. This may be the case 
where, for example, a specific group is 
under-represented in treatment or access 
to other services, or where there has 
been significant demographic change. 
Commissioners and providers of local 
services should consider putting in place 
systems to determine the baseline level and 
nature of needs, and should plan and deliver 
services accordingly. However, where data 
and information are not available at a local 
level, this should not inhibit the provision 
of appropriate services to meet assumed 
or anticipated needs. The extent to which 
this provision meets the needs of all 
communities should be monitored, and this 
information should inform ongoing delivery.
Commissioners and providers of local 
services should consider further the 
individual and social harms that may be 
brought about by the use of khat, where 
local assessments identify needs related 
to the use of this substance. Particular 
consideration should be given to culturally 
appropriate responses to the needs of khat 
users and members of a user’s family. 
A number of responses to the drug 
strategy consultation raised issues relating 
to diversity and equality. Further issues 
were raised during the Equality Impact 
Assessment process which accompanied 
the development of the strategy. While 
these issues will be addressed in greater 
detail in each of the three-year action 
plans underpinning the delivery of the 
strategy, consideration should be given by 
commissioners and providers of services to 
key issues, including:
access to services for women with •	
children;
the provision of culturally competent •	
services, including meeting language 
needs;
addressing wider issues of identity, •	
particularly for those of dual heritage;
providing family-based services which •	
address the needs of all families, as most 
widely defined; and
investigating the means by which •	
information might be obtained which 
will determine patterns of drug use and 
service needs, particularly where there 
are significant gaps in evidence, such 
as the needs of lesbian, gay, bisexual, 
transgender and transsexual (LGBT) 
people.
Government commitments
In order to improve our understanding of the 
degree to which needs are being met, the 
Government will conduct an analysis of the 
sources of data and information relating to 
diversity that are available at a national and 
local level. We will also consider conducting 
a qualitative study of the experiences of 
key equality target groups in accessing 
drug services, to inform future planning 
and provision. 
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In 2008, the National Treatment Agency and 
the Healthcare Commission are conducting 
a national Improvement Review into diversity 
in drug treatment. Each local partnership’s 
performance on diversity and drug treatment 
will be benchmarked and results will be 
available in September 2008. Each area 
found to be scoring below average will be 
required to produce an action plan setting 
out steps to be taken to improve. The lowest 
10 per cent will receive a plan of targeted 
improvement work covering the period from 
September 2008 to January 2009. Progress 
against action plans will be monitored 
thereafter through regional mechanisms. 
Guidance on good practice, drawn from the 
best performing local partnerships, will be 
published by March 2009.
In addition, an independent national Drug 
Strategy Diversity Forum will meet on an 
ad hoc basis to consider specific issues 
which have arisen or which pose risks to 
delivery and to advise the Government on 
issues relating to diversity and equality. 
The action plans that will support delivery 
of the strategy, and the reports on progress 
against those plans, will be published 
on a regular basis, demonstrating the 
Government’s commitment to ensuring 
equality in the provision of services for 
all communities. 
Community engagement
In planning services to meet the needs 
of local communities, consideration 
should be given to the role of community 
engagement in this process. While this 
may be conducted on an informal basis, 
engagement of all communities should be 
integral to the commissioning process. 
Not only does such engagement inform 
the planning process, but it can also 
provide evidence of the degree to which 
needs are being met, and can provide a 
route to demonstrate accountability to 
the community. Further information and 
resources on community engagement can 
be found on the website of the University 
of Central Lancashire’s Centre for Ethnicity 
and Health (www.uclan.ac.uk/facs/health/
ethnicity/communityengagement/) and 
the Home Office Crime Reduction website 
(www.crimereduction.homeoffice.gov.uk/
learningzone/passporttoce.htm).
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Appendix 4
Workforce issues
Providing appropriate, safe and effective 
drug interventions is a key objective of 
the drug strategy and the availability of an 
adequately skilled workforce is essential 
to meet this objective.
The workforce involved in addressing 
substance misuse is broad, encompassing 
those working with adults, children and 
young people and those in specialised and 
mainstream services in education, treatment 
and justice. They provide a range of services 
across prevention, early intervention, 
specialist treatment, enforcement and 
reintegration. This requires a workforce that 
is drawn from a wide range of practitioners 
from diverse backgrounds and with diverse 
skills and knowledge.
Within each sector, there are roles ranging 
from substance misuse specialist workers to 
those professionals whose work brings them 
into contact with drug and alcohol misuse 
less frequently or only occasionally. The 
following diagram represents the workforce 
which will be involved in addressing 
substance misuse:
   This wider group includes those who, as 
part of their work, will occasionally deal with 
substance misuse. This group of practitioners 
will encounter the impact of substance misuse 
and therefore have a significant role to play in 
addressing and preventing substance misuse.
   Others are employed in posts with a more 
significant substance misuse role. The 
successful implementation of the drug 
strategy is reliant upon all related sectors 
recognising and fulfilling their roles in relation 
to substance misuse. The substance misuse 
field relates not only to the specialised 
treatment of problematic drug users but also 
to the broader approaches of prevention and 
aftercare.
   This group is made up of specialist 
practitioners whose roles primarily involve 
working with substance misuse.
GENERIC 
WORKERS
with occasional 
substance misuse 
functions
GENERIC 
WORKERS
with a substance 
misuse function 
within their 
portfolio
SPECIALIST 
DRUG AND 
ALCOHOL 
WORKERS
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The competence of the workforce has a 
crucial relationship to the achievement of 
the aims of the drug strategy. A very broad 
range of workers have a role to play in 
addressing substance misuse. Substance 
misuse should, therefore, be regarded as 
core business for many services, including 
those that do not have a primary drug or 
alcohol focus. 
Core competencies have been identified 
for the adult health and social care sector 
and the children’s workforce, which are also 
considered to be core competencies for the 
substance misuse field. In addition, every 
role in the drug and alcohol field requires a 
particular set of role-specific competencies. 
Depending on role and setting, some of 
these will be generic, others more specific 
to the substance misuse field. Many whose 
work brings them into contact with drug and 
alcohol misuse already have professional 
qualifications. They may be social workers, 
youth workers or probation officers, but 
they may lack the skills, knowledge and 
understanding to deal with the impact of 
substance misuse problems on their day-to-
day work and duties. For example, all those 
working with vulnerable individuals need to 
have a basic knowledge and understanding 
of substance misuse.
Developing a competent substance misuse 
workforce, including both generic and 
specialist practitioners, is crucial to ensuring 
a high standard of service delivery. Local 
areas should take the necessary steps 
to ensure there are adequate numbers of 
appropriately skilled, competent and trained 
staff to meet local needs. It is also important 
to seek to ensure that the workforce reflects 
the diversity of the local population and 
each agency should ensure that drugs and 
the drugs workforce are reflected in their 
equality schemes.
Sources of information, guidance and 
support are available on the http://drugs.
homeoffice.gov.uk website or from the 
relevant sector skills council. 
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Appendix 5
Evidence review*
This appendix summarises the most 
recent evidence on illicit drug use, supply, 
intervention and prevention. It is divided 
into seven sections:
prevalence of drug use in key •	
populations;
drug use in young people•	
drug-related harms;•	
prevention and young people;•	
what works in drug treatment;•	
drug-related crime and interventions to •	
reduce offending; and
drug supply and enforcement.•	
Prevalence of drug use in 
key populations
The primary sources of measurement of 
trends and changes in the prevalence 
of self-reported drug use in the general 
population of adults and young people are: 
the British Crime Survey (BCS: population 
aged 16–59); the Offending, Crime and 
Justice Survey (OCJS: those aged 10–25); 
and the Smoking, Drinking and Drug Use 
Survey of young people of school age 
(those aged 11–15). The prevalence of drug 
use among those arrested by the police is 
measured by the Arrestee Survey.
In addition to these prevalence measures, 
national estimates are produced for the 
numbers of problematic drug users (those 
using opiates and/or crack cocaine) as 
these groups are relatively small in number, 
hard to reach and thus estimates of their 
numbers can provide a useful supplement to 
household surveys such as the BCS.**
Drug use in 16–59-year-olds 
The latest BCS survey1 (2006/07) shows 
that overall reported drug use in the 
past year is down since the previous drug 
strategy commenced from 12.1 per cent in 
1998 to 10 per cent in 2006/07. This is the 
lowest reported level of illicit drug use since 
the BCS started measurement in 1996. 
Declining cannabis use, which is the most 
widely used drug in this population, has 
driven this trend.
The 2006/07 BCS estimates that more than 
one third (35.5 per cent; this equates to 
around 11.3 million people) of 16–59-year-
olds have used one or more illicit drugs in 
their lifetime, 10 per cent in the last year (just 
under 3.2 million people) and 5.9 per cent in 
the past month (almost 2 million people). 
The proportion of those reporting the use 
of Class A drugs in the last year increased 
between 1996 and 2005/06, but has 
remained stable since then. The rise in Class 
A drug use was largely due to an increase 
in the self-reported use of powder cocaine 
between 1998 and 2000 (self-reported use 
in the last month was 0.4 per cent in 1998 
compared with 0.7 per cent in 2000: self-
reported lifetime ‘ever used’ was 3.7 per 
cent in 1998 compared with 5.5 per cent 
in 2000). Nearly 14 per cent (just under 4.5 
million people) reported using a Class A 
drug at least once in their lifetime; 3.4 per 
cent (just over 1 million) in the past year, and 
nearly 2 per cent (just over half a million) in 
the past month.
* This paper has been peer reviewed by academic experts in the field.
** Please note that all figures are reported as in original publications. 
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Drug use in young people 
Drug use in young people  
(16–24-year-olds)
We know from the 2006/07 BCS that in 
terms of overall drug use, young people 
are the largest consumers of illicit drugs. 
Young people are far more likely to report 
recent drug use (in the last month and the 
last year) than the older age groups: 24 per 
cent of young people surveyed by the BCS 
in 2006/07 reported using illicit drugs in the 
last year compared with 10 per cent of the 
overall BCS population. The average age 
for first drug use is 162 and the typical first 
drugs tried are cannabis and solvents.3
Use of Class A drugs among young people 
is currently stable: in 2006/07, 8 per cent 
of young people reported using a Class A 
drug, compared with 8.6 per cent in 1998. 
The 20–24-year-old age group report a 
higher level of Class A drug use than the 
16–19-year-old age group.
Drug use among school children and 
youth
Around one in four (24 per cent) of 
secondary school children in 2006 reported 
using one or more drugs in their lifetime, 
17 per cent in the past year, and 9 per cent 
in the past month, and a small minority 
of school children were using drugs 
regularly, with 4 per cent reporting taking 
drugs usually once a month. However, 
the prevalence of illicit drug use among 
secondary school-age children has fallen 
in recent years. The 2006 Schools Survey4 
shows that, since 2001, prevalence of drug 
use in the past year in this age group has 
fallen from 20 per cent in 2001 to 17 per 
cent in 2006. This is mainly due to a drop in 
cannabis use. 
School children tend to use alcohol and 
tobacco more than they use illicit drugs, but 
the likelihood of all self-reported substance 
use increases with age through adolescence. 
The Schools Survey shows that, at the age 
of 11, 21 per cent had ever drunk alcohol, 
13 per cent had smoked and 10 per cent 
had tried drugs at least once. By the age 
of 15, the comparable figures were 82, 61 
and 40 per cent.
Vulnerable young people
Some groups of young people are 
particularly vulnerable to drug use:  
looked-after children, homeless children, 
those who truant and are excluded from 
school and those who are serious and 
frequent offenders are particularly at risk 
of drug use. For example, 5 per cent of 
non-vulnerable young people in the 2003 
Offending, Crime and Justice Survey 
(OCJS) used any drug frequently in the 12 
months prior to interview, while 24 per cent 
of vulnerable young people were frequent 
users of any drug in the same time period.5
Truanting and exclusion appear to be 
particular markers for illicit drug use in 
the Schools Survey, but other factors 
are associated, including: poor parental 
discipline or monitoring; parental drug use; 
peer drug use; and drug availability. There 
is more mixed evidence for the role played 
by mental health, school performance and 
socioeconomic status.6
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Problem drug users
Problem drug users (PDUs) are defined as 
those using opiates (e.g. heroin, morphine, 
codeine) and/or crack cocaine. PDUs are 
of particular interest because it is estimated 
they account for 99 per cent of the costs to 
society of Class A drug misuse.7
While this group is difficult to estimate with 
precision, we know from the PDU estimates 
work8 that nationally there are significant 
numbers of people engaging in this type of 
drug use – estimated to be approximately 
332,000 PDUs in 2005/06, with these 
estimates remaining stable over the last 
two annual data sweeps. 
Various factors impact on the prevalence 
estimates of PDUs. For example there are 
large regional variations. It is estimated that 
there are 14.35 PDUs per 1,000 population 
in London, whereas in the South East 
Government Office Region it is estimated 
there are 6.4 PDUs per 1,000 population. 
Prevalence varies according to demographic 
factors; for example it is estimated that 
there are three times more male than female 
PDUs and the estimated rate of problem 
drug use among people aged 25–34 is 
much higher than for those aged between 
10–24 and 35–64.
Criminal Justice System and drug use
High rates of drug use tend to be found 
among those within the criminal justice 
system. 
Around half (52 per cent) of those surveyed 
for the Arrestee Survey reported using 
drugs within the past month.9 The most 
commonly reported drug used within the 
previous month was cannabis (41 per 
cent), but 26 per cent had taken heroin, 
crack, or powder cocaine (HCC). Of those 
reporting drug use within the year previous 
to arrest, 15 per cent reported heroin use 
and 15 per cent reported crack use. This 
is a higher rate than that reported in the 
general adult population – heroin 0.1 per 
cent and crack 0.2 per cent. Polydrug use 
among arrestees who had used heroin and/
or crack (HC) in the past month was 15 per 
cent. The link between dependent alcohol 
use and cocaine among arrestees was also 
highlighted in the survey – 78 per cent of 
those who had used powder cocaine in the 
past year were dependent drinkers. 
In addition to high rates of reported drug 
use in those arrested, very high rates of 
drug use are found among people entering 
prison. Around 73 per cent of prisoners 
have used drugs in the year before entering 
prison, nearly half of whom report using 
HCC (47 per cent). Of the 73 per cent, half 
reported committing offences connected to 
their drug use.10 
Drug-related harms
Drug use, particularly of Class A drugs, 
is responsible for considerable socio-
economic harms. For example, the 
economic and social costs of Class A 
drug use were estimated to be around 
£15.4 billion in 2003/04.11 
Drug-related deaths are also a major 
concern: there were 1,608 drug-related 
deaths in 200512 and recent research 
indicates that about 15 per cent of these 
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deaths occur in people who have recently 
left prison.13 Drug users also tend to have 
higher rates of mental health problems than 
the general population.14
The Drug Harm Index (DHI) has been used 
to measure Government performance in 
reducing drug harms. It measures drug 
harms by combining national indicators of 
the harms generated by illicit drugs into a 
single-figure time-series index. The harms 
include drug-related crime, community 
perceptions of drug problems and the 
various health consequences that arise 
from illicit drug use (e.g. HIV, overdoses 
and death). The DHI captures a subset of 
all the harms generated by drug use for 
which the most robust data (or information) 
are available. Data from the DHI15 show 
that drug harms have decreased since the 
introduction of the Updated Drug Strategy in 
2002, although the rate of this decline eased 
in 2005.
Evidence surrounding the harms, particularly 
the health harms, associated with young 
people’s illicit drug use indicates that deaths 
related to drug misuse among those aged 
under 20 almost halved between 2000 
and 2004, falling from 70 to 37,16 and 
as with adults, involvement in crime is a 
significant drug-associated harm for the 
young. Additionally, long-term mental health 
problems may be a consequence of young 
people’s drug use. For example, regular use 
of cannabis has been found to predict an 
increased risk of depression and anxiety.17
Prevention and young people
The Government has funded several 
prevention programmes for young people 
through the Young People and Drugs 
Programme, including FRANK (the national 
drug awareness campaign), Blueprint 
(a multi-modal school-based education 
programme), Positive Futures (a social 
inclusion programme for at-risk young 
people), and the High Focus Area Initiative.
Evidence on the delivery of these 
programmes and activities indicates that:
FRANK is a well-regarded and well-used •	
campaign;18
Blueprint has been well-received by •	
practitioners;19, 20 and
the High Focus Area Initiative•	 21 has 
improved services for young people in 
48 priority areas.
The UK evidence on effectiveness is limited, 
but the wider evidence base suggests 
that, in general, the benefits of prevention 
programmes outweigh the costs, even 
where there is only a small change in 
behaviour.22 
What works in drug treatment
General drug treatment
Treatment to address drug use can take 
many forms and an extensive evidence base 
informs the policy and clinical decisions that 
are made to provide the best outcomes for 
those using drugs.23 We know that drug 
treatment can be cost-effective and that 
evidence suggests for every £1 spent on 
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drug treatment at least £9.50 in crime and 
health costs can be saved.24
In terms of specific treatments, methadone 
maintenance is effective in reducing illicit 
opiate use, criminal behaviour, injecting 
and sharing behaviours, HIV infection 
rates, and mortality.25, 26, 27 Psychosocial 
approaches can also be successful. For 
example family therapy, mutual aid, the 
community reinforcement approach and 
contingency management, when paired with 
pharmacological interventions have been 
found to be successful in reviews of the 
treatment of opiate addiction.28, 29 A recent 
review of psychosocial interventions for 
those with problems related to a number of 
drugs of misuse has found positive evidence 
for the impact of brief interventions including 
self-help, contingency management and 
behavioural couples therapy for drug-
specific problems.30
Drug treatment is often most effective when 
combined with additional support to tackle 
the underlying contributory factors for 
drug use – factors such as homelessness, 
long-term unemployment or mental health 
problems. For example, the majority of 
rough sleepers are problem drug users and 
homelessness is a barrier to other elements 
of wraparound care.31 Most treatment 
seekers (77 per cent) are unemployed and 
more than one-third (38 per cent) have left 
school before the age of 16.32 Furthermore, 
mental health problems suffered by drug 
users, left unaddressed, can impact 
negatively on drug treatment outcomes.33
Services are developing which are aimed 
at supporting drug users in treatment and 
in re-establishing their lives. We know 
that drug users are more likely to stay 
in treatment, and the treatment is more 
effective, if wraparound care is part of 
the treatment strategy.34, 35 For example, 
meeting the housing needs of drug users 
significantly reduces drug use36, 37 and drug 
users who receive specialist outpatient 
mental health care have been found to 
achieve better outcomes than those who 
do not complete treatment.38 Employment 
and treatment are also linked. For example, 
successful completion of treatment 
significantly improves the probability of 
employment after treatment.39
Treatment specific to young people
Young drug users make up a significant 
number in the population of treatment 
service users. Figures from the National 
Drug Treatment Monitoring System 2003–04 
show that 5 per cent of those in drug 
treatment were aged 11–17; this equates 
to 6,530 11–17-year-olds.
In terms of what works in treating drug 
users, there is evidence that simultaneously 
addressing individual, familial and extra-
familial risk factors can successfully reduce 
drug use.40 Behaviour therapy, culturally 
sensitive counselling, family therapy and 
group and individual therapy have also been 
found to reduce drug use among young 
people, while family therapy is effective in 
reducing young drug users’ psychological 
problems.41 Brief interventions can help 
to divert young people with less severe 
substance misuse problems away from 
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developing more severe problems42 and 
there is some evidence of effectiveness of 
brief interventions, such as a short session 
of motivational interviewing, in producing 
short-term reductions in frequency of 
cannabis and stimulant use among young 
people.43
By contrast, it has been suggested that 
purely educational programmes are 
generally ineffective in reducing drug use44, 45 
and there is little research which evaluates 
the effectiveness of pharmacological 
treatment for young people, although 
extrapolation from the evidence base on 
adults can be considered.46
One of the challenges for the future of 
effective drug treatment in all populations 
will be how evidence-based practice can 
be consistently rolled out across the drug 
treatment sector so as to achieve the 
benefits seen in research trials.
Drug-related crime and 
interventions to reduce 
offending
Drug use and crime
The relationship between drug use and 
crime is complex. It is widely accepted that 
there is a correlation between the use of 
certain drugs and offending, particularly 
acquisitive offending.47 However, the exact 
nature and direction of the link between 
drugs and crime is less clear.48 So while 
studies49, 50 have shown a correspondence 
between drug use and offending behaviour, 
not all drug users commit crime.
There is undoubtedly a population of drug 
users for whom drugs and crime are closely 
intertwined. Around three-quarters of new 
entrants to custody report using heroin or 
cocaine in the 12 months prior to interview.51 
Arrestees report high levels of drug use, and 
particularly those arrested for acquisitive 
crimes; the majority (73 per cent) of those 
using HC at least once a week were arrested 
for an acquisitive crime. Twenty-six per cent 
of those arrested for committing acquisitive 
crime reported taking HC weekly.52
Interventions to reduce offending
There is evidence that interventions which 
aim to reduce offending by addressing the 
drug use of dependent users who offend, 
do work to reduce offending.53 Research 
shows that drug treatment can achieve 
reductions in offending behaviour.54, 55, 56 
There is also evidence that semi-coercive 
approaches, such as the Drug Interventions 
Programme (DIP), ‘Tough Choices’ initiative 
and community drug treatment orders, 
can produce good rates of engagement 
in treatment and that DIP and community 
drug treatment orders are also associated 
with reductions in offending behaviour.57 
There is also international evidence for the 
effectiveness of drug courts in reducing 
drug-related crime.58 More generally, 
aftercare and wraparound provision are 
associated with better outcomes for 
prisoners.59
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In terms of effective treatment approaches, 
a National Institute of Clinical Excellence 
(NICE) ‘Technology Appraisal’ of methadone 
and buprenorphine reported that the level 
of criminal activity decreased in people on 
methadone maintenance treatment (MMT) 
compared with those on placebo or no 
therapy,60 and that substitute (methadone 
or buprenorphine) treatment, heroin 
treatment, therapeutic communities with 
psychosocial approaches, drug courts and 
probation supervision can all be effective 
in reducing drug-related re-offending and 
other harms.61, 62, 63, 64 For example, there is 
evidence of a reduction in offending among 
prisoners entering methadone treatment 
in prison prior to release (and retention in 
MMT was also associated with reduced 
mortality, incarceration rates and hepatitis C 
infection).65, 66
Other studies have found that prison-based 
substitution treatment, especially prison-
based methadone maintenance treatment, 
can reduce re-incarceration rates67 and 
that, in particular, prison-initiated high-dose 
methadone maintenance had a statistically 
significant impact on re-incarceration 
versus lower-dose methadone maintenance 
therapy.68
There is little evidence on the impact of 
routine monitoring drug testing (i.e. drug 
testing undertaken pre-trial or in conjunction 
with treatment).69 However, there is 
evidence to show that drug testing in the 
custody suite, through DIP, increases the 
numbers of individuals entering treatment 
when combined with other appropriate 
interventions, such as required assessment.
Drug supply and enforcement
Our evidence base on the supply of drugs 
to and within the UK (including the nature 
of supply networks) has been developed 
partly from intelligence from law enforcement 
agencies and other government sources, 
and partly from empirical research including 
self-report data from drug users and dealers. 
The illicit drug market 
The illicit drug market in the UK, based 
on a combined market for cannabis, 
cocaine powder, heroin, crack, ecstasy 
and amphetamines in 2003/04, was worth 
between an estimated £4 billion and  
£6.6 billion; the estimated figure for England 
and Wales is between £3.5 billion and  
£5.8 billion. Crack and heroin accounted for 
the largest expenditure share, 28 per cent 
and 23 per cent respectively.70
Between 25 and 35 tonnes of heroin and 
35 and 45 tonnes of cocaine powder enter 
the UK each year. The UK heroin market is 
supplied almost exclusively by Afghanistan, 
which produces over 90 per cent of the 
world’s heroin. Colombia supplies the 
majority of the cocaine that comes into 
the UK.71 Crack cocaine is rarely imported 
but is produced in the UK from cocaine 
powder. Cannabis is imported to the 
UK from Europe, both in bulk by serious 
organised criminals and in smaller amounts 
for sale and personal use. In addition, some 
cannabis is cultivated in the UK.72
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Drug prices and purity
Law enforcement data indicates that the 
price of drugs at street level has fallen 
over the past decade. In recent years 
(2003–2006), the prices of heroin, cannabis 
resin, ecstasy and cocaine have also fallen, 
while those of crack and amphetamines 
have remained broadly stable.73 
These data are supported by the views of 
drug users and dealers. Those interviewed 
for the 2005/06 Arrestee Survey reported 
a perceived drop in the price of drugs 
compared with six months previously.74 
Similarly, drug dealers interviewed in prison 
claimed a reduction in drug prices over time, 
particularly wholesale prices.75 
The purity of most drugs at street level 
is falling, with the exception of heroin. 
Respondents in the Arrestee Survey (2005/06 
sweep) also reported a drop in drug purity 
levels compared to six months previously. 
The relationship between drug prices, drug 
purity and demand for drugs is complex, 
although there is evidence that increases in 
drug prices can reduce adverse outcomes 
of drug use.76 Interviews with drug dealers 
and traffickers have suggested that law 
enforcement activity can impact on how 
drugs are priced.77 However, dealers 
working at different levels of the market 
handle price fluctuations in different ways, 
for example, dealers operating at the upper 
levels of the market (i.e. importation) may 
raise prices in response to a reduction in 
availability, while street level dealers are 
more likely to keep prices stable to keep 
their customers while adjusting the purity or 
the weight of drugs sold.
Enforcement activity
Since the introduction of the drug strategy 
in 1998, the Government has implemented 
a number of initiatives aimed at reducing 
and disrupting the supply of drugs in the 
UK. These initiatives have sought to adopt 
a multi-agency approach to enforcement, 
working in partnership with local agencies 
in the community to tackle drug supply. 
A systematic review of the international 
evidence on law enforcement interventions 
has shown that adopting this approach to 
enforcement to tackle specific problems 
in the community, e.g. street level dealing, 
is more successful than enforcement in 
isolation.78 
Enforcement activity in the UK has included 
the introduction of the Anti-social Behaviour 
Act (2003), which enables the police to 
enforce the rapid closure of crack houses. 
These increased powers enable the police 
to tackle drug supply and drug taking 
in communities and reduce anti-social 
behaviour. However, some displacement has 
occurred with cases involving crack houses 
opening in neighbouring areas. Effective 
partnership working with local agencies, 
including treatment providers, proved key 
in the period following these operations, 
providing support for drug users and the 
local community.79
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In addition, middle market police operations 
that focused on dealers distributing drugs 
from upper-level to street-level dealers were 
set up in the West Midlands, Merseyside 
and Wales. These operations signified a 
move towards intelligence-led policing, 
targeting key players in the supply chain, 
and led to significant arrests and large 
seizures of drugs.80 The longer-term impacts 
of such initiatives on drug markets and 
those supplying them are not yet known.
In terms of the deterrent effect of 
enforcement activity, drug dealers claim 
that the risk of having their assets seized 
is a greater deterrent than is the risk of 
imprisonment.81
Next steps
Looking ahead, the Government will seek 
to develop a strategic research programme 
over the next ten years that draws on 
enhanced partnership working between 
government, academia and the wider 
international research community in order 
to further develop our evidence base 
and support the delivery of our new drug 
strategy. A first stage of such work will be to 
identify the priority areas for future research.
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Appendix 6
Links to other strategies
The drug strategy and the Public Service 
Agreements (PSAs) underpinning its 
delivery are closely related to a number of 
strategies and PSAs across a broad range 
of areas. Action to meet objectives and 
targets set out in the drug strategy and 
its supporting action plans will contribute 
to the objectives set out in a number 
of other strategies. Conversely, the 
delivery of several strategies will support 
the achievement of the drug strategy 
objectives.
The closest links are between the drug 
strategy and the alcohol strategy, and the 
single PSA that informs the content of both 
strategies sets out the Government’s vision 
to reduce the harms caused by alcohol and 
drugs.
The strategies, plans and programmes 
linked to the drug strategy are listed below:
Crime and offending
Working Together to Cut Crime and •	
Deliver Justice: A Strategic Plan for 
2008–2011, Criminal Justice System, 
2007 
Cutting Crime: A New Partnership  •	
2008–2011, Home Office, 2007 
National Community Safety Plan •	
2008–2011, Home Office, 2007
Youth Crime Action Plan•	 , Department for 
Children, Schools and Families (DCSF)/
Home Office/Ministry of Justice (MoJ), 
summer 2008
Reducing Re-Offending Strategic Plan •	
2008–2011, MoJ, spring 2008
Reducing Re-Offending by ex-prisoners•	 , 
Social Exclusion Unit, 2002 and The 
National Reducing Re-offending Delivery 
Plan, National Offender Management 
Service (NOMS), 2005
Reducing Re-Offending Through •	
Skills and Employment: Next Steps, 
Department for Education and Skills 
(DfES), 2006
Strategy for the Management and •	
Treatment of Problematic Drug Users 
Within the Correctional Services, NOMS, 
2005
Saving Lives, Reducing Harm, Protecting •	
the Public. An action plan for tackling 
violence 2008–2011, Home Office, 2008
Working together to protect the public•	 . 
The Home Office Strategy 2008–2011, 
Home Office, 2008
Young people and families
Reaching Out: Think Family•	 , Cabinet 
Office, 2007 and Think Family: Improving 
the life chances of families at risk, 
Cabinet Office, 2008
Hidden Harm – responding to the needs •	
of children of problem drug users, 
Advisory Council on the Misuse of Drugs 
(ACMD), 2003 and Hidden Harm Three 
Years On, ACMD, 2007
The Children’s Plan: Building brighter •	
futures, DCSF, 2007
Aiming high for young people: A ten •	
year strategy for positive activities, 
HM Treasury/DCSF, 2007
Guidance for schools on the duty to •	
promote well-being, DCSF, spring 2008
Drug education review, DCSF, •	
spring 2008
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Sex and relationships education review, •	
DCSF, spring 2008
Pupil well-being guidance, DCSF, •	
spring 2008
Staying Safe: Action Plan•	 , DCSF, 2008
Every Child Matters: Change for Children •	
– Young People and Drugs, DfES, 2005
Youth Alcohol Action Plan•	 , DCSF, 
summer 2008 
Care Matters: Time for Change•	 , White 
Paper, DCSF, 2007
Children and Young People’s Health •	
Strategy, Department of Health (DH)/
DCSF, summer 2008
Every Parent Matters•	 , DCSF, 2007
Duty to provide information, advice and •	
assistance: guidance for local authorities, 
DCSF, 2008
Teenage Pregnancy Next Steps: •	
Guidance for Local Authorities and 
Primary Care Trusts on Effective Delivery 
of Local Strategies, DfES, July 2006
Teenage Pregnancy: Accelerating the •	
Strategy to 2010, DfES, September 2006
Teenage Parents Next Steps: Guidance •	
for Local Authorities and Primary Care 
Trusts, DCSF/DH, July 2007
Health
Our health, our care, our say•	 , DH, 2005
Government response to •	 Facing the 
future: A review of the role of health 
visitors, DH, 2007
Treatment effectiveness strategy•	 , National 
Treatment Agency (NTA), 2005
Substance specific
Safe. Sensible. Social. The next steps •	
in the National Alcohol Strategy, Home 
Office, 2007
Children, Young People and Volatile •	
Substance Abuse (VSA), DH, 2005
Addressing Alcohol Misuse: A Prison •	
Service Alcohol Strategy for Prisoners, 
HM Prison Service (HMPS), 2004
Working with Alcohol Misusing Offenders •	
– a strategy for delivery, NOMS, 2005
Wider context
Strong and Prosperous Communities:•	  
The Local Government White Paper, 
Department for Communities and Local 
Government (CLG), 2006
Reaching Out: An Action Plan on Social •	
Exclusion, Cabinet Office, 2006
Independence and Opportunity: Our •	
Strategy for supporting people, CLG, 2007
Sustainable Communities: settled homes; •	
changing lives – A strategy for tackling 
homelessness, Office of the Deputy 
Prime Minister (ODPM), 2005
Home for the Future: more affordable, •	
more sustainable, CLG, 2007
Housing for vulnerable people: Strategy •	
statement, Housing Corporation, 2007
The Home Office Overarching Race, •	
Disability and Gender Equality Scheme, 
Home Office, 2007
The diversity strategy 2007–10•	 ,  
Home Office, 2007
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International
Relevant international strategies:
EU Drugs Strategy 2005–2012•	 , adopted 
by the Council on 22 November 2004; 
Council document number 15074/04
The EU drugs action plan 2009–12, •	
to be developed between July and 
December 2008
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Appendix 7
National governance
Within central government, a system 
of governance has been put in place 
for the drug strategy that provides a 
mechanism by which cabinet ministers, 
junior ministers and senior officials 
retain oversight of the development and 
delivery of the strategy, and within which 
issues may be resolved at the most 
appropriate level.
The governance arrangements are closely 
related to, and in some cases combined 
with, the governance systems relating to 
crime and alcohol. This recognises the fact 
that the drivers and effects of drug misuse 
are closely related to those for alcohol 
and crime. Departments and agencies 
representing young people and families are 
represented at each level of the structure, 
which ensures shared objectives and a close 
link between officials and ministers. 
Issues relating to drugs will also be within 
the remit of boards and governance 
systems with a focus on related issues. 
Examples of this relationship are the 
Reducing Re-Offending Programme Board 
and the Inter-Ministerial Group on Reducing 
Re-Offending, which monitor progress, 
provide direction and drive strategy at, 
respectively, official and ministerial level 
across the seven pathways to reduce 
re-offending, one of which is alcohol and 
drugs. 
The governance structure is represented in the table below. 
BOARD CHAIR LEVEL
Domestic Affairs Cabinet  
Sub-Committee (Justice 
and Crime)
Secretary of State for Justice Cabinet
National Crime Reduction 
Board
Home Secretary Ministerial
Inter-Ministerial Group: 
alcohol and drugs
Parliamentary Under-Secretary of State for 
Crime Reduction (Home Office) or Minister 
of State for Public Health (Department of 
Health)
Public Service Agreement 
strategic board  
(PSAs 23 and 25)
Director General, Crime Reduction and 
Community Safety Group (Home Office)
Senior 
official
Alcohol and drug strategies 
delivery group
Director, Crime and Drug Strategy 
Directorate (Home Office) or Department of 
Health equivalent
Individual programme 
boards – alcohol and drugs
Departmental policy leads Operational
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Appendix 8
Impact assessment
Addressing the harms caused by drugs 
is a long-term problem. This strategy 
replaces the existing ten-year strategy, 
which was published in 1998 and updated 
in 2002.
It builds upon the existing strategy and 
seeks to balance tough enforcement action 
to tackle dealers, reduce crime and anti-
social behaviour and reduce the supply 
of drugs, with interventions to prevent 
drug use, educate and intervene early and 
reduce the demand for illegal drugs. The 
overarching aims are to grip existing drug 
users more firmly, increase the numbers 
already re-establishing their lives and 
reducing the number of new problem drug 
users. It is focused on the drugs which 
cause the greatest harm to communities. 
The strategy is arranged around four 
strategic themes:
protecting communities through robust •	
enforcement to tackle drug supply, drug-
related crime and anti-social behaviour;
preventing harm to children, young •	
people and families affected by drug 
misuse;
delivering new approaches to drug •	
treatment and social re-integration; and,
public information campaigns, •	
communications and community 
engagement.
The strategy document makes explicit 
reference to the public consultation process 
which helped to inform its development and 
it addresses the priority issues raised.
While the strategy will cover a ten-
year period to 2018, its delivery will be 
underpinned by a series of three-year action 
plans, which will run concurrently with the 
Spending Review cycles. The first such 
action plan is published with this document.
Key actions include:
identifying and targeting the drug-•	
misusing offenders causing the greatest 
harm to communities, improving prison 
treatment programmes and increasing 
the use of community sentences with a 
drug rehabilitation requirement; 
extending powers to seize the cash and •	
assets of drug dealers, to demonstrate to 
communities that dealing doesn’t pay;
embedding action to tackle drugs within •	
the neighbourhood policing approach, to 
gather community intelligence, engage 
with and increase community confidence;
strengthening and extending international •	
agreements to intercept drugs being 
trafficked to the UK;
focusing on the families where parents •	
misuse drugs, intervening early to 
prevent harm to children, prioritising 
parents’ access to treatment where 
children are at risk, providing intensive 
parenting guidance and supporting family 
members, such as grandparents, who 
take on caring responsibilities;
developing a package of support to help •	
people in drug treatment to complete 
treatment and to re-establish their lives, 
including ensuring local arrangements are 
in place to refer people from Jobcentres 
to sources of housing advice and 
advocacy and appropriate treatment;
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using opportunities presented by the •	
benefits system to support people in 
re-integrating into communities and 
gaining employment, while also exploring 
the case for introducing a new regime for 
drug users that provides more tailored 
support for people; and, in return, putting 
the responsibility on claimants to move 
successfully through treatment and into 
employment; and
piloting new approaches which allow •	
more flexible and effective use of 
resources, including individual budgets to 
meet treatment and wider support needs.
We have carefully considered the impact 
of the strategy upon all sectors. There are 
no adverse financial impacts on the private 
or third sectors. The private sector benefits 
from the impact of less need to cope with 
the disruption caused by drug-related 
The impact of the key strategic themes are:
STRATEGIC THEMES IMPACT
Protecting communities through robust 
enforcement to tackle drug supply, drug-
related crime and anti-social behaviour.
Reduced drug-related crime, anti-social 
behaviour and safer communities. Improved 
public confidence and reduced perceptions 
of drug problems in local areas.
Preventing harm to children, young people 
and families affected by drug misuse.
Fewer young people becoming involved in 
drugs, leading to fewer problem drug users 
in the future.
Delivering new approaches to drug 
treatment and social re-integration.
Problem drug users successfully 
completing treatment and re-establishing 
their lives.
Public information campaigns, 
communications and community 
engagement
General public and at-risk groups 
better informed on drug problems, and 
communities more motivated to collaborate 
on crime.
acquisitive crime, reduced impact of anti-
social behaviour upon business premises 
and their surroundings and reduced health 
harms. The third sector benefits in similar 
ways.
Evidence suggests that for every £1 that is 
spent on drug treatment, at least £9.50 is 
saved in crime and health costs.
Anticipated beneficial outcomes include:
Police and other enforcement agencies’ •	
resources more efficiently deployed in 
addressing all aspects of drug-related 
crime. This will result in better targeting 
of drug-misusing offenders causing 
greatest harm, reducing their impact 
upon communities; and all levels of drug 
supply being disrupted more effectively. 
Criminal assets, the proceeds of drug 
supply, will be seized and re-invested for 
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the benefit of enforcement agencies and 
local communities.
Better use of family-oriented initiatives. •	
Our understanding of those who are 
most at risk has improved. We are now 
able to target resources more effectively, 
intervening earlier to prevent harm, 
prioritising parents’ access to treatment 
and supporting family members to take 
on caring responsibilities.
Maximising the benefits of treatment •	
and the development of more outcome-
focused, personalised and innovative 
provision, including the piloting of 
individual budgets to support end-to-end 
management to help those successfully 
completing treatment to re-integrate 
by accessing housing, employment, 
education and training support. The 
medium-term impact is that former 
problem drug users make fewer calls on 
support services and cause less harm to 
themselves and others.
Better information support for parents, •	
as well as young people, to help them to 
talk about drugs. We will broaden the use 
of information campaigns to better equip 
those surrounding our vulnerable young 
people to support and help address drug 
issues.
Strengthened community confidence •	
through improved local communications 
about the way drug harms are being 
tackled, so that communities are more 
strongly motivated to engage with 
enforcement agencies in tackling local 
drugs crime and anti-social behaviour.
We are confident that the overall package of 
measures set out will produce the benefits 
we describe. We do not anticipate the need 
for further legislation nor any additional costs 
or unwanted impacts falling on frontline 
services. However, if further more detailed 
proposals are required we will produce 
robust impact assessments as necessary.
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Appendix 9
Resources
The following tables set out estimates 
of the resources being invested by 
government departments in the various 
component programmes and funding 
streams which enable delivery of the 
drug strategy. There is also significant 
mainstream and LAA funding which is 
used to support action to tackle drugs. 
While funding decisions have been made 
for 2008/09, the first year of the strategy, it 
is not possible for us to determine precisely 
the funding that will be available for each 
strand or constituent programme of the 
strategy, so figures for later years are 
therefore indicative. However, tackling drugs 
is a key element of government policy and 
we therefore expect that total expenditure 
will remain broadly constant.
Labelled expenditure is defined as that 
which is:
included in budgets and/or end-of-year •	
reports;
drug-specific; and•	
proactive, in that it is linked to the •	
achievement of specific policy aims.
Additional related expenditure may be 
proactive, such as drug education, or 
reactive, in that it arises as a result of drug 
misuse, such as enforcement or health 
costs.
Departmental expenditure £ million
2007/08 2008/09 2009/10 2010/11
Department of Health and other 
mainstream treatment 
568.22 568.22 568.22* 568.22*
Young People drug-specific services 
funding for local delivery (combined 
Department of Health, Department for 
Children, Schools and Families, Youth 
Justice Board and Home Office funding)
55.20 55.10 55.10* 55.10*
Young People central programmes 
funding (combined Department of Health, 
Department for Children, Schools and 
Families, Youth Justice Board and Home 
Office funding)
33.81 31.61 31.61 31.61
Home Office 160.39 160.39 160.39 160.39
Prison funding and community 
sentences (combined Ministry of Justice 
and Department of Health funding)
118.10 127.10 141.60* 145.60*
Foreign and Commonwealth Office 6.00 3.00 2.00 2.00
Total labelled expenditure 941.72 945.42 958.92 962.92
* Note that the Pooled Treatment Budget for 2009-11 is due to be confirmed in July 2008.
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Additional related expenditure £ million
Departmental expenditure 2007/08 2008/09 2009/10 2010/11
All relevant agencies – tackling supply 380 380 380 380
DCSF – teacher time, school-based training 
and schools Standards Fund
49 49 49 49
Re-integration support and 
community-based services
122 122 122 122
DWP – providing help to find jobs 20 20 20 20
Prisons re-integration 0 0 2 2
DCSF – investment in youth† 606.66 606.66 606.66
DCSF – investment in families† 52.66 52.66 52.66
FCO – Support to Afghanistan† 16.5 16.5 16.5 16.5
†We have shown DCSF investment in youth and families, and FCO investment to support 
the government of Afghanistan, as constant expenditure over the three year period for 
indicative purposes only. Detailed content over each year has yet to be defined.
During the course of the previous drug 
strategy, the Government made significant 
year-on-year increases in funding, and this 
has enabled robust and effective delivery 
mechanisms and systems to be put in 
place. We would now expect that, as 
this system reaches maturity, expansion 
costs should be minimised and substantial 
efficiency savings should be generated. This 
will allow the available resources to be more 
effectively used.
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